Unnamed: 0 stringlengths 3 8 | Date stringlengths 23 23 | Article_title stringlengths 1 250 | Stock_symbol stringlengths 1 5 | Url stringlengths 44 135 | Publisher stringclasses 1
value | Author stringclasses 1
value | Article stringlengths 1 343k | Lsa_summary stringlengths 3 53.9k | Luhn_summary stringlengths 1 53.9k | Textrank_summary stringlengths 1 53.9k | Lexrank_summary stringlengths 1 53.9k |
|---|---|---|---|---|---|---|---|---|---|---|---|
37400.0 | 2020-06-21 00:00:00 UTC | 3 Stocks You Don't Want to Be Holding When the Market Crashes Again | ACB | https://www.nasdaq.com/articles/3-stocks-you-dont-want-to-be-holding-when-the-market-crashes-again-2020-06-21 | nan | nan | More than 20 million Americans are out of work and receiving unemployment benefits, largely due to the COVID-19 pandemic. And yet, you wouldn't know that there's a problem in the economy from looking at the markets. The S&P 500 is up over 5% since March 1, which is around the time the coronavirus was just starting to w... | Aurora Cannabis Aurora Cannabis (NYSE: ACB) is a volatile investment whether there's a market crash or not. That means for the period of July through September, Aurora is expecting to have a profitable earnings before interest taxes depreciation and amortization (EBITDA) figure. Throw widespread lockdowns and a market ... | Aurora Cannabis Aurora Cannabis (NYSE: ACB) is a volatile investment whether there's a market crash or not. If there's a run on the markets, highly volatile pot stocks like Aurora could go into free fall, even if the company meets its ambitious targets for Q1. Kohl's Kohl's (NYSE: KSS) is a bit of a safer buy than a po... | Aurora Cannabis Aurora Cannabis (NYSE: ACB) is a volatile investment whether there's a market crash or not. A market crash could send investors heading for safety and stocks that are stable (e.g. not cannabis stocks). Takeaway for investors Here's how all three stocks measure up against the S&P 500 this year: TSLA data... | Aurora Cannabis Aurora Cannabis (NYSE: ACB) is a volatile investment whether there's a market crash or not. If sales don't rise during what's still a very volatile period, and if Aurora can't keep its costs down, the company could fall short of its expectations. A market crash can come without warning, and when it does... |
37401.0 | 2020-06-21 00:00:00 UTC | 2 Reasons to Stay Away From HEXO After Its Blowout Third Quarter | ACB | https://www.nasdaq.com/articles/2-reasons-to-stay-away-from-hexo-after-its-blowout-third-quarter-2020-06-21 | nan | nan | HEXO (NYSE: HEXO) released its earnings report for the third quarter of fiscal year 2020 on June 11, and the pot grower managed to impress investors for a change. During this quarter, HEXO's net revenue of 22.1 million Canadian dollars increased by 70% year-over-year and 30% sequentially. The cannabis company also seem... | Aurora Cannabis (NYSE: ACB) recently resorted to this option to avoid being delisted. The company is hoping that thanks to the launch of several products -- including the recent introduction of a large-sized (30-gram) format of its popular Tsunami cannabis flower -- its sales will continue growing. Back in 2018, the tw... | Aurora Cannabis (NYSE: ACB) recently resorted to this option to avoid being delisted. During the third quarter, HEXO's operating expenses came in at CA$26.8 million, significantly better than the CA$281.5 million operating expenses the company recorded during the second quarter. Further, HEXO's net loss of CA$19.5 mill... | Aurora Cannabis (NYSE: ACB) recently resorted to this option to avoid being delisted. During the third quarter, HEXO's operating expenses came in at CA$26.8 million, significantly better than the CA$281.5 million operating expenses the company recorded during the second quarter. In fact, the company's shares spent enou... | Aurora Cannabis (NYSE: ACB) recently resorted to this option to avoid being delisted. The pot grower raised CA$46 million in an underwritten public offering in April, issuing nearly 60 million new shares (and even more warrants) in the process. Investors looking to buy cannabis stocks would be much better off with eith... |
37402.0 | 2020-06-20 00:00:00 UTC | Canada Marijuana Sales Slump in April After Coronavirus Stockpiling | ACB | https://www.nasdaq.com/articles/canada-marijuana-sales-slump-in-april-after-coronavirus-stockpiling-2020-06-20 | nan | nan | Canadians seem to be easing off marijuana a bit, at least as far as the latest sales figures reveal. On Friday, Statistics Canada released its national retail sales data for April, revealing that purchases from licensed marijuana stores fell slightly (by 1%) on a month-over-month basis to land at around 180 million Can... | Still, the very modest decline relative to overall retail sales will be particularly encouraging for investors in the top Canadian cannabis producers and sellers like Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB). Cannabis dispensaries were an exception, however, as in most Canadian geographies they were co... | Still, the very modest decline relative to overall retail sales will be particularly encouraging for investors in the top Canadian cannabis producers and sellers like Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB). Though April's sales figure represents a decline, marijuana as a category actually held up rel... | Still, the very modest decline relative to overall retail sales will be particularly encouraging for investors in the top Canadian cannabis producers and sellers like Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB). On Friday, Statistics Canada released its national retail sales data for April, revealing that... | Still, the very modest decline relative to overall retail sales will be particularly encouraging for investors in the top Canadian cannabis producers and sellers like Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB). Though April's sales figure represents a decline, marijuana as a category actually held up rel... |
37403.0 | 2020-06-19 00:00:00 UTC | Aurora Cannabis Leap Frogs Canopy Growth as a Better Investment | ACB | https://www.nasdaq.com/articles/aurora-cannabis-leap-frogs-canopy-growth-as-a-better-investment-2020-06-19 | nan | nan | For years now, Aurora Cannabis (ACB) and Canopy Growth (CGC) have traded in near lockstep based on the global growth potential of cannabis. The latest quarterly results set Aurora Cannabis a step ahead of their prime competitor in Canada.
Aurora Cannabis reported an exceptional turnaround quarter for March, but the sto... | For years now, Aurora Cannabis (ACB) and Canopy Growth (CGC) have traded in near lockstep based on the global growth potential of cannabis. "ACB is a company with a credible turnaround plan, not going bust, and with little further dilution risk. ACB is a close #2 in Canada rec to Canopy Growth; it is #1 in Canada med w... | For years now, Aurora Cannabis (ACB) and Canopy Growth (CGC) have traded in near lockstep based on the global growth potential of cannabis. "ACB is a company with a credible turnaround plan, not going bust, and with little further dilution risk. ACB is a close #2 in Canada rec to Canopy Growth; it is #1 in Canada med w... | For years now, Aurora Cannabis (ACB) and Canopy Growth (CGC) have traded in near lockstep based on the global growth potential of cannabis. "ACB is a company with a credible turnaround plan, not going bust, and with little further dilution risk. ACB is a close #2 in Canada rec to Canopy Growth; it is #1 in Canada med w... | For years now, Aurora Cannabis (ACB) and Canopy Growth (CGC) have traded in near lockstep based on the global growth potential of cannabis. "ACB is a company with a credible turnaround plan, not going bust, and with little further dilution risk. ACB is a close #2 in Canada rec to Canopy Growth; it is #1 in Canada med w... |
37404.0 | 2020-06-19 00:00:00 UTC | Why Marijuana Stocks HEXO and Organigram Holdings Got Trounced on Friday | ACB | https://www.nasdaq.com/articles/why-marijuana-stocks-hexo-and-organigram-holdings-got-trounced-on-friday-2020-06-19 | nan | nan | What happened
HEXO (NYSE: HEXO) and Organigram Holdings (NASDAQ: OGI) both declined more steeply than the overall stock market on Friday (in excess of 3% in both cases).
What seems to have triggered this sell-off is a new class action lawsuit that hit the headlines that day, in which HEXO and Organigram -- among other ... | What seems to have triggered this sell-off is a new class action lawsuit that hit the headlines that day, in which HEXO and Organigram -- among other Canadian marijuana companies -- were named as defendants. So what The suit, brought by a woman named Lisa Marie Langevin, alleges that these companies sold cannabis produ... | What seems to have triggered this sell-off is a new class action lawsuit that hit the headlines that day, in which HEXO and Organigram -- among other Canadian marijuana companies -- were named as defendants. The lawsuit considers all Canadians who bought medical marijuana products from HEXO, Organigram, and 13 other bu... | What seems to have triggered this sell-off is a new class action lawsuit that hit the headlines that day, in which HEXO and Organigram -- among other Canadian marijuana companies -- were named as defendants. The lawsuit considers all Canadians who bought medical marijuana products from HEXO, Organigram, and 13 other bu... | The lawsuit considers all Canadians who bought medical marijuana products from HEXO, Organigram, and 13 other businesses in the sector, including Aurora Cannabis and Tilray, between June 16, 2010 and the present day to be potential members of the class. The Motley Fool owns shares of and recommends OrganiGram Holdings.... |
37405.0 | 2020-06-19 00:00:00 UTC | Why Tilray Is Still a Very Risky Cannabis Stock | ACB | https://www.nasdaq.com/articles/why-tilray-is-still-a-very-risky-cannabis-stock-2020-06-19 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Despite posting higher losses that grew by over five-fold year-over-year in the first quarter, Tilray’s (NASDAQ:TLRY) stock is still attracting buyers. If the cannabis supplier’s revenue is growing rapidly but it’s losing more money, why should any investo... | The list includes Aurora Cannabis (NYSE:ACB), Cronos Group (NASDAQ:CRON), and Canopy Growth (NYSE:CGC). 10 Robotics Stocks on the Technological Cutting Edge Tilray attributed its $1.73 per share loss to a change in the fair value of its warrants held by investors. But as the country permits more legal stores to open, t... | The list includes Aurora Cannabis (NYSE:ACB), Cronos Group (NASDAQ:CRON), and Canopy Growth (NYSE:CGC). InvestorPlace - Stock Market News, Stock Advice & Trading Tips Despite posting higher losses that grew by over five-fold year-over-year in the first quarter, Tilray’s (NASDAQ:TLRY) stock is still attracting buyers. T... | The list includes Aurora Cannabis (NYSE:ACB), Cronos Group (NASDAQ:CRON), and Canopy Growth (NYSE:CGC). InvestorPlace - Stock Market News, Stock Advice & Trading Tips Despite posting higher losses that grew by over five-fold year-over-year in the first quarter, Tilray’s (NASDAQ:TLRY) stock is still attracting buyers. B... | The list includes Aurora Cannabis (NYSE:ACB), Cronos Group (NASDAQ:CRON), and Canopy Growth (NYSE:CGC). Brendan Kennedy, Tilray’s CEO, said that “while the positive impact of these actions are not fully reflected in this quarter’s results, they will become more clearly evident over the course of this year.” Though Tilr... |
37406.0 | 2020-06-19 00:00:00 UTC | Marijuana Stock Short Interest Is Picking Up Again | ACB | https://www.nasdaq.com/articles/marijuana-stock-short-interest-is-picking-up-again-2020-06-19 | nan | nan | For much of the past half-decade, marijuana stocks were among the hottest investments on Wall Street. Investors who were able to stomach the industry's early-stage volatility were treated to gains that occasionally topped 1,000% as of 2018 and early 2019.
But over the past 14 months, the cannabis bubble has undeniably ... | Aurora Cannabis After more than doubling in value following the release of its fiscal third-quarter operating results, short interest in Aurora Cannabis (NYSE: ACB) increased by 15% from the previous month to 21.3 million shares. Although Aurora produced higher-than-expected sales in its fiscal third-quarter report and... | Aurora Cannabis After more than doubling in value following the release of its fiscal third-quarter operating results, short interest in Aurora Cannabis (NYSE: ACB) increased by 15% from the previous month to 21.3 million shares. During the month of May, Canopy Growth (NYSE: CGC) witnessed its shares held short rocket ... | Aurora Cannabis After more than doubling in value following the release of its fiscal third-quarter operating results, short interest in Aurora Cannabis (NYSE: ACB) increased by 15% from the previous month to 21.3 million shares. Ontario-headquartered licensed-producer Cronos Group (NASDAQ: CRON) has seen the number of... | Aurora Cannabis After more than doubling in value following the release of its fiscal third-quarter operating results, short interest in Aurora Cannabis (NYSE: ACB) increased by 15% from the previous month to 21.3 million shares. With this cash accounting for 58% of Cronos' market cap as of June 17, you'd think investo... |
37407.0 | 2020-06-18 00:00:00 UTC | With Executive Departures Continuing, This Analyst Remains Bearish on Aurora (ACB) Cannabis Stock | ACB | https://www.nasdaq.com/articles/with-executive-departures-continuing-this-analyst-remains-bearish-on-aurora-acb-cannabis | nan | nan | It has been a headline-grabbing 2020 for Canadian cannabis producer Aurora (ACB). There has been a reverse stock split, an entrance into the U.S. CBD space via its Reliva acquisition and a much better-than-expected fiscal Q3 earnings report.
All of which have steered Aurora further away from the edge over which it was ... | It has been a headline-grabbing 2020 for Canadian cannabis producer Aurora (ACB). Dobler’s exit follows those of COO Cam Battley, who left last year, and CEO and co-founder Terry Booth, who parted ways with the company during February’s restructuring. Considering there have been other high profile exits this year, as m... | It has been a headline-grabbing 2020 for Canadian cannabis producer Aurora (ACB). There has been a reverse stock split, an entrance into the U.S. CBD space via its Reliva acquisition and a much better-than-expected fiscal Q3 earnings report. Considering there have been other high profile exits this year, as more CPG-fo... | It has been a headline-grabbing 2020 for Canadian cannabis producer Aurora (ACB). With the search for a new CEO beginning in February, there will be many who would have hoped that a release today may have been related to this rather than a further executive departure.” Bennett, though, alleviates any concerns that Dobl... | It has been a headline-grabbing 2020 for Canadian cannabis producer Aurora (ACB). Bennett said, “The continuation of executive departures is obviously not helpful for sentiment, but what we think is actually more damaging is the lack of new replacements. In our view, the market (retail investors especially) are hoping ... |
37408.0 | 2020-06-18 00:00:00 UTC | 2 Stocks I’d Avoid at All Costs | ACB | https://www.nasdaq.com/articles/2-stocks-id-avoid-at-all-costs-2020-06-18 | nan | nan | Because of the ongoing COVID-19 pandemic, the past few months have been scary for investors. The stock market's volatile movements over this period have been hard to predict, and it is still difficult to know how things will evolve in the short term. However, I remain confident that the market will eventually recover o... | By contrast, during their latest reported quarters, Aphria (NASDAQ: APHA), Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) reported revenue of CA$144.4 million, CA$75.5 million, and CA$107.9 million, respectively. Cronos's deal with Altria meant that the company now had a partner with deep pockets, industry k... | By contrast, during their latest reported quarters, Aphria (NASDAQ: APHA), Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) reported revenue of CA$144.4 million, CA$75.5 million, and CA$107.9 million, respectively. During the first quarter, Cronos reported net revenue of CA$8.4 million. While BioXcel may have ... | By contrast, during their latest reported quarters, Aphria (NASDAQ: APHA), Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) reported revenue of CA$144.4 million, CA$75.5 million, and CA$107.9 million, respectively. Cronos At first glance, Cronos may look like an attractive stock to buy, and this is for one maj... | By contrast, during their latest reported quarters, Aphria (NASDAQ: APHA), Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) reported revenue of CA$144.4 million, CA$75.5 million, and CA$107.9 million, respectively. With that said, though, I think this biotech stock remains risky, and most investors will want t... |
37409.0 | 2020-06-16 00:00:00 UTC | Despite Doubling, These Cannabis Stocks Are Bad News | ACB | https://www.nasdaq.com/articles/despite-doubling-these-cannabis-stocks-are-bad-news-2020-06-16 | nan | nan | If you think the stock market has had a wild go of things lately, take a gander at marijuana stocks over the past three years.
Until the end of the first quarter of 2019, pot stocks were virtually unstoppable. Promises of increased capacity, partnerships, and high-margin derivatives fueled upside, with Wall Street seem... | Aurora Cannabis As if it weren't already a polarizing marijuana stock, Aurora Cannabis (NYSE: ACB) is attracting all sorts of attention after rallying 127% over the trailing month, through this past weekend. Supply issues in select Canadian provinces, high tax rates on legal product in the U.S., financing concerns thro... | Aurora Cannabis As if it weren't already a polarizing marijuana stock, Aurora Cannabis (NYSE: ACB) is attracting all sorts of attention after rallying 127% over the trailing month, through this past weekend. Tilray Another seemingly unstoppable cannabis stock of late is Tilray (NASDAQ: TLRY). Similar to Aurora, Tilray'... | Aurora Cannabis As if it weren't already a polarizing marijuana stock, Aurora Cannabis (NYSE: ACB) is attracting all sorts of attention after rallying 127% over the trailing month, through this past weekend. Aurora's fiscal third-quarter operating results have served as the upside catalyst, with the company reporting a... | Aurora Cannabis As if it weren't already a polarizing marijuana stock, Aurora Cannabis (NYSE: ACB) is attracting all sorts of attention after rallying 127% over the trailing month, through this past weekend. Until the end of the first quarter of 2019, pot stocks were virtually unstoppable. Over the trailing month, ende... |
37410.0 | 2020-06-16 00:00:00 UTC | Aurora Cannabis' $80 Million Mistake | ACB | https://www.nasdaq.com/articles/aurora-cannabis-%2480-million-mistake-2020-06-16 | nan | nan | Every company makes its fair share of mistakes. Aurora Cannabis (NYSE: ACB) is no exception.
Just over the last 12 months, the Canadian cannabis producer has reported several abysmal quarterly results (although with a pleasantly positive surprise in its most recent quarter). It temporarily lost the right to market medi... | Aurora Cannabis (NYSE: ACB) is no exception. Alcanna was then working to achieve its goal of opening as many as 50 retail cannabis stores under the Aurora brand name by the end of the year with expectations of a booming recreational marijuana market after the scheduled launch in October 2018. By November 2019, Alcanna ... | Aurora Cannabis (NYSE: ACB) is no exception. Back in February 2018, Aurora announced that it was investing CA$103.5 million in Alcanna, then known as Liquore Stores N.A., for a 19.9% ownership stake. At the same time that Aurora was increasing its stake, Alcanna reported that it was trying to regain lost market share i... | Aurora Cannabis (NYSE: ACB) is no exception. A "transformation" deal gone awry On June 3, 2020, Aurora announced that is was selling 9.2 million shares of Alberta-based liquor store chain Alcanna (OTC: LQSIF) through a bought-deal offering for total proceeds of 27.6 million in Canadian dollars. Aurora Cannabis founder ... | Aurora Cannabis (NYSE: ACB) is no exception. Both management teams at Aurora and Alcanna thought that the combination of Aurora's leadership in the cannabis industry with Alcanna converting some of its existing liquor stores into cannabis retail locations would create a retail cannabis power in western Canada. At the s... |
37411.0 | 2020-06-15 00:00:00 UTC | Aurora Is Too Risky to Buy and Too Risky to Short | ACB | https://www.nasdaq.com/articles/aurora-is-too-risky-to-buy-and-too-risky-to-short-2020-06-15 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Aurora Cannabis (NYSE:ACB) has been a strong performer as of late, with Aurora stock rallying over 74% in the past month. But, as investors jump back into cannabis plays like this one, should you join them?
Source: Shutterstock
It’s debatable. With potentia... | Why ACB Is Vulnerable to Short Squeezes It seems inevitable that the company will pursue dilutive stock sales to improve its finances. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurora Cannabis (NYSE:ACB) has been a strong performer as of late, with Aurora stock rallying over 74% in the past month. ... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurora Cannabis (NYSE:ACB) has been a strong performer as of late, with Aurora stock rallying over 74% in the past month. Why Aurora Stock Faces a Tough Road Ahead After beating on earnings, and indicating its financial situation was stronger than previousl... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurora Cannabis (NYSE:ACB) has been a strong performer as of late, with Aurora stock rallying over 74% in the past month. Why ACB Is Vulnerable to Short Squeezes It seems inevitable that the company will pursue dilutive stock sales to improve its finances. ... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurora Cannabis (NYSE:ACB) has been a strong performer as of late, with Aurora stock rallying over 74% in the past month. Why Aurora Stock Faces a Tough Road Ahead After beating on earnings, and indicating its financial situation was stronger than previousl... |
37412.0 | 2020-06-14 00:00:00 UTC | Should I Sell My Aurora Cannabis Stock? | ACB | https://www.nasdaq.com/articles/should-i-sell-my-aurora-cannabis-stock-2020-06-14 | nan | nan | Punk rock group The Clash framed one of the most important questions ever in the lines of the memorable song, "Should I Stay or Should I Go?" That's a key question that investors should ask themselves from time to time with respect to the individual stocks that they own.
One such stock that I suspect many investors are... | One such stock that I suspect many investors are evaluating right now is Aurora Cannabis (NYSE: ACB). Punk rock group The Clash framed one of the most important questions ever in the lines of the memorable song, "Should I Stay or Should I Go?" The most important factors in addressing the confidence issue with Aurora, t... | One such stock that I suspect many investors are evaluating right now is Aurora Cannabis (NYSE: ACB). The third main reason to sell a stock is if you feel strongly that you could make a higher return by investing elsewhere. The company generated strong revenue growth. | One such stock that I suspect many investors are evaluating right now is Aurora Cannabis (NYSE: ACB). Should you sell Aurora Cannabis stock? The definitive answer We still haven't gotten to that promised definitive answer to whether or not you should sell Aurora Cannabis stock at the outset. | One such stock that I suspect many investors are evaluating right now is Aurora Cannabis (NYSE: ACB). So when should you sell a stock? Do you still believe the cannabis market will grow significantly? |
37413.0 | 2020-06-14 00:00:00 UTC | 3 Cheap Stocks for Contrarian Investors | ACB | https://www.nasdaq.com/articles/3-cheap-stocks-for-contrarian-investors-2020-06-14 | nan | nan | It's easy to jump on the bandwagon and invest in stocks that are performing well. However, being a contrarian investor can yield even stronger returns -- if you're right.
Contrarian investors buy shares of companies that the markets aren't optimistic about, to effectively bet that a turnaround will happen. That means c... | Aurora Cannabis Aurora Cannabis (NYSE: ACB) has lost 85% of its value over the past year as the S&P 500 index has risen 11%. And that makes them risky buys because even if cruise lines start operating again, demand is likely to be a fraction of what it would've been without the fear of a pandemic weighing on people's m... | Aurora Cannabis Aurora Cannabis (NYSE: ACB) has lost 85% of its value over the past year as the S&P 500 index has risen 11%. Royal Caribbean Royal Caribbean Cruises (NYSE: RCL) stock is down around 50% over the past year. And that makes them risky buys because even if cruise lines start operating again, demand is likel... | Aurora Cannabis Aurora Cannabis (NYSE: ACB) has lost 85% of its value over the past year as the S&P 500 index has risen 11%. The pot stock's a risky buy but it's also trading at 0.6 times its book value and around 6.5 times its revenue; it's not an expensive buy and is a lot cheaper than where it was months ago. Royal ... | Aurora Cannabis Aurora Cannabis (NYSE: ACB) has lost 85% of its value over the past year as the S&P 500 index has risen 11%. Contrarian investors buy shares of companies that the markets aren't optimistic about, to effectively bet that a turnaround will happen. But one reason to swim against the tide and believe in Roy... |
37414.0 | 2020-06-14 00:00:00 UTC | 2 Cannabis Stocks That Should Survive the COVID-19 Crisis | ACB | https://www.nasdaq.com/articles/2-cannabis-stocks-that-should-survive-the-covid-19-crisis-2020-06-14 | nan | nan | What's essential for businesses when a crisis like the COVID-19 pandemic hits is to keep operating and try to make it out of the crisis without running out of money. Almost all the sectors are tumbling, with many companies facing the prospect of bankruptcy.
In most places, the marijuana industry was deemed essential a... | But lately, it's the only Canadian cannabis company to report consistently positive profitability -- in an industry susceptible to wild cash burn rates and earnings before interest, taxes, depreciation, and amortization (EBITDA) losses. Aphria also drove a chunk of revenue from its distributor CC Pharma in Germany, whi... | Cronos has launched a variety of vape products for the Canadian market, including cannabis vaporizer devices under the Cove and Spinach brands and its Peace Naturals branded cannabis vaporizers.These "Cannabis 2.0" products are cannabis derivatives (beverages, edibles, and vapes) that are part of the second wave of Can... | Cronos has launched a variety of vape products for the Canadian market, including cannabis vaporizer devices under the Cove and Spinach brands and its Peace Naturals branded cannabis vaporizers.These "Cannabis 2.0" products are cannabis derivatives (beverages, edibles, and vapes) that are part of the second wave of Can... | Canada's cannabis sales made up CA$64.4 million of total revenue. Aphria has CA$515.1 million of cash and cash equivalents at the end of the third quarter and additional equity capital of CA$100 million. And make no mistake – it is coming. |
37415.0 | 2020-06-11 00:00:00 UTC | Can HEXO Save Itself From Collapsing? | ACB | https://www.nasdaq.com/articles/can-hexo-save-itself-from-collapsing-2020-06-11 | nan | nan | An outstanding pot stock that rose when Canada first legalized cannabis seems to be collapsing this year. HEXO (NYSE: HEXO) saw a fair share of bad news in 2019.
It repeatedly missed its earnings and revenue guidance last year, which put the company in a cash crunch. The resignation of Chief Financial Officer Michael M... | Aurora Cannabis (NYSE: ACB) had a similar case, but it chose to execute a 1-for-12 reverse stock split on May 11 before it could receive a warning from the NYSE. Canadian cannabis companies' lower revenues last year were the product of the slower rollout of legal stores, rising illicit market sales, and other regulator... | Aurora Cannabis (NYSE: ACB) had a similar case, but it chose to execute a 1-for-12 reverse stock split on May 11 before it could receive a warning from the NYSE. Cannabis 2.0 refers to Canada's legalization of cannabis derivatives, including beverages, edibles, and vapes. That led to an earnings before interest, taxes,... | Aurora Cannabis (NYSE: ACB) had a similar case, but it chose to execute a 1-for-12 reverse stock split on May 11 before it could receive a warning from the NYSE. Canadian cannabis companies' lower revenues last year were the product of the slower rollout of legal stores, rising illicit market sales, and other regulator... | Aurora Cannabis (NYSE: ACB) had a similar case, but it chose to execute a 1-for-12 reverse stock split on May 11 before it could receive a warning from the NYSE. Aurora also grew revenue 20.4% year over year in its recent third quarter, but it's yet to record a profit. Stock dilution usually doesn't go over well with i... |
37416.0 | 2020-06-11 00:00:00 UTC | Cresco Labs Had a Good Start to 2020. Can It Keep It Up? | ACB | https://www.nasdaq.com/articles/cresco-labs-had-a-good-start-to-2020.-can-it-keep-it-up-2020-06-11 | nan | nan | U.S. cannabis companies are certainly catching attention this year. No doubt, they were overlooked while eyes were on the bigger Canadian cannabis players, like Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC). But while the bigger names failed to impress with their downfall the past few quarters, Illinois-bas... | No doubt, they were overlooked while eyes were on the bigger Canadian cannabis players, like Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC). But while the bigger names failed to impress with their downfall the past few quarters, Illinois-based Cresco Labs (OTC: CRLBF) is emerging as a good cannabis pick for ... | No doubt, they were overlooked while eyes were on the bigger Canadian cannabis players, like Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC). Staggering revenue growth Cresco Labs' incredible revenue growth of 215% in the first quarter is a proof of the rising cannabis demand in the U.S. Besides Cresco, Illin... | No doubt, they were overlooked while eyes were on the bigger Canadian cannabis players, like Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC). Staggering revenue growth Cresco Labs' incredible revenue growth of 215% in the first quarter is a proof of the rising cannabis demand in the U.S. In the first quarter,... | No doubt, they were overlooked while eyes were on the bigger Canadian cannabis players, like Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC). Staggering revenue growth Cresco Labs' incredible revenue growth of 215% in the first quarter is a proof of the rising cannabis demand in the U.S. Besides Cresco, Illin... |
37417.0 | 2020-06-10 00:00:00 UTC | Buy Canopy Growth Stock as Cannabis Again Enters the Spotlight | ACB | https://www.nasdaq.com/articles/buy-canopy-growth-stock-as-cannabis-again-enters-the-spotlight-2020-06-10 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Cannabis isn’t going away, and when momentum returns, Canopy Growth (NYSE:CGC) will be the one that feels the lift. CGC stock is the true leader among cannabis stocks. But when the industry is under pressure, leadership can be a bad thing.
Source: Shutterst... | While there are many lower-quality companies in the space — like Tilray (NASDAQ:TLRY) and Aurora Cannabis (NYSE:ACB) — traders viewed Canopy as a go-to short. Source: Shutterstock For instance, when the cannabis trade started to break down in summer 2019, CGC stock had no way of avoiding the pain. The post Buy Canopy G... | While there are many lower-quality companies in the space — like Tilray (NASDAQ:TLRY) and Aurora Cannabis (NYSE:ACB) — traders viewed Canopy as a go-to short. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cannabis isn’t going away, and when momentum returns, Canopy Growth (NYSE:CGC) will be the one tha... | While there are many lower-quality companies in the space — like Tilray (NASDAQ:TLRY) and Aurora Cannabis (NYSE:ACB) — traders viewed Canopy as a go-to short. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cannabis isn’t going away, and when momentum returns, Canopy Growth (NYSE:CGC) will be the one tha... | While there are many lower-quality companies in the space — like Tilray (NASDAQ:TLRY) and Aurora Cannabis (NYSE:ACB) — traders viewed Canopy as a go-to short. CGC stock is the true leader among cannabis stocks. 7 Pharmaceutical Stocks to Buy for Post-Pandemic Gains For instance, current assets stand at 2.5 billion CAD,... |
37418.0 | 2020-06-08 00:00:00 UTC | Aurora Cannabis: 3 Things That Must Happen for Investor Trust to Be Rebuilt | ACB | https://www.nasdaq.com/articles/aurora-cannabis%3A-3-things-that-must-happen-for-investor-trust-to-be-rebuilt-2020-06-08 | nan | nan | At one time, there wasn't a hotter investment on Wall Street than marijuana stocks. Though there were a number of North American licensed producers that investors fancied, Alberta-based Aurora Cannabis (NYSE: ACB) was often the favorite.
Aurora Cannabis appeared to have a pedigree that would make it a clear winner in t... | Though there were a number of North American licensed producers that investors fancied, Alberta-based Aurora Cannabis (NYSE: ACB) was often the favorite. Within the past nine months, we've seen Aurora Cannabis enact a 1-for-12 reverse split to avoid delisting from the New York Stock Exchange, lay off 500 workers, rewor... | Though there were a number of North American licensed producers that investors fancied, Alberta-based Aurora Cannabis (NYSE: ACB) was often the favorite. Within the past nine months, we've seen Aurora Cannabis enact a 1-for-12 reverse split to avoid delisting from the New York Stock Exchange, lay off 500 workers, rewor... | Though there were a number of North American licensed producers that investors fancied, Alberta-based Aurora Cannabis (NYSE: ACB) was often the favorite. Even though Aurora Cannabis was able to access some traditional bank financing, the vast majority of its capital has come from selling its own common stock or using i... | Though there were a number of North American licensed producers that investors fancied, Alberta-based Aurora Cannabis (NYSE: ACB) was often the favorite. This would make Aurora the global leader in marijuana production, and presumably allow the company to take advantage of economy-of-scale cost reductions. The point be... |
37419.0 | 2020-06-08 00:00:00 UTC | Vireo Health Fires Bruce Linton | ACB | https://www.nasdaq.com/articles/vireo-health-fires-bruce-linton-2020-06-09 | nan | nan | Multistate operator Vireo Health (OTC: VREOF) announced on Monday that it was terminating its contract with Executive Chairman Bruce Linton. The former Canopy Growth (NYSE: CGC) CEO joined the U.S. company last November. Vireo doesn't plan to replace Linton and says the termination is "on an entirely without-cause basi... | Back in February, Aurora Cannabis (NYSE: ACB) CEO Terry Booth referred to himself as the "latest carnage" after he parted ways with the Canadian pot producer. Multistate operator Vireo Health (OTC: VREOF) announced on Monday that it was terminating its contract with Executive Chairman Bruce Linton. In July of last year... | Back in February, Aurora Cannabis (NYSE: ACB) CEO Terry Booth referred to himself as the "latest carnage" after he parted ways with the Canadian pot producer. In July of last year, Linton was fired as co-CEO of Canopy Growth just days after beer maker Constellation Brands (NYSE: STZ), which invested $4 billion in the p... | Back in February, Aurora Cannabis (NYSE: ACB) CEO Terry Booth referred to himself as the "latest carnage" after he parted ways with the Canadian pot producer. In July of last year, Linton was fired as co-CEO of Canopy Growth just days after beer maker Constellation Brands (NYSE: STZ), which invested $4 billion in the p... | Back in February, Aurora Cannabis (NYSE: ACB) CEO Terry Booth referred to himself as the "latest carnage" after he parted ways with the Canadian pot producer. Multistate operator Vireo Health (OTC: VREOF) announced on Monday that it was terminating its contract with Executive Chairman Bruce Linton. Here's The Marijuana... |
37420.0 | 2020-06-08 00:00:00 UTC | Why Aurora Cannabis, HEXO, Cronos Group, and Other Cannabis Stocks Surged Today | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-hexo-cronos-group-and-other-cannabis-stocks-surged-today-2020-06-08 | nan | nan | What happened
Marijuana stocks soared on Monday, as investors grew more optimistic about the cannabis industry. Many of the largest companies enjoyed sharp gains on the day, including:
HEXO (NYSE: HEXO), up 47.4%
Cronos (NASDAQ: CRON), up 21.5%
OrganiGram Holdings (NASDAQ: OGI), up 15.4%
Aphria (NASDAQ: APHA), up 13.4%... | Many of the largest companies enjoyed sharp gains on the day, including: HEXO (NYSE: HEXO), up 47.4% Cronos (NASDAQ: CRON), up 21.5% OrganiGram Holdings (NASDAQ: OGI), up 15.4% Aphria (NASDAQ: APHA), up 13.4% Aurora Cannabis (NYSE: ACB), up 12.9% Canopy Growth (NYSE: CGC), up 8.7% So what Several factors likely contrib... | Many of the largest companies enjoyed sharp gains on the day, including: HEXO (NYSE: HEXO), up 47.4% Cronos (NASDAQ: CRON), up 21.5% OrganiGram Holdings (NASDAQ: OGI), up 15.4% Aphria (NASDAQ: APHA), up 13.4% Aurora Cannabis (NYSE: ACB), up 12.9% Canopy Growth (NYSE: CGC), up 8.7% So what Several factors likely contrib... | Many of the largest companies enjoyed sharp gains on the day, including: HEXO (NYSE: HEXO), up 47.4% Cronos (NASDAQ: CRON), up 21.5% OrganiGram Holdings (NASDAQ: OGI), up 15.4% Aphria (NASDAQ: APHA), up 13.4% Aurora Cannabis (NYSE: ACB), up 12.9% Canopy Growth (NYSE: CGC), up 8.7% So what Several factors likely contrib... | Many of the largest companies enjoyed sharp gains on the day, including: HEXO (NYSE: HEXO), up 47.4% Cronos (NASDAQ: CRON), up 21.5% OrganiGram Holdings (NASDAQ: OGI), up 15.4% Aphria (NASDAQ: APHA), up 13.4% Aurora Cannabis (NYSE: ACB), up 12.9% Canopy Growth (NYSE: CGC), up 8.7% So what Several factors likely contrib... |
37421.0 | 2020-06-08 00:00:00 UTC | Ontario Cannabis Store Online Transactions Soar 82% in March | ACB | https://www.nasdaq.com/articles/ontario-cannabis-store-online-transactions-soar-82-in-march-2020-06-08 | nan | nan | The Ontario Cannabis Store (OCS) has released data on its sales over the past 12 months, from April 1, 2019, until March 31, 2020. In total, for the full fiscal year, the OCS website generated 71.4 million Canadian dollars while the government-run retail stores brought in CA$313.7 million in revenue.
In March, the OCS... | Aurora proving to be a dominant brand The OCS' report also broke down the top five brands, and Ontario-based Aurora Cannabis (NYSE: ACB) was popular among customers. The Ontario Cannabis Store (OCS) has released data on its sales over the past 12 months, from April 1, 2019, until March 31, 2020. In March, the OCS' onli... | Aurora proving to be a dominant brand The OCS' report also broke down the top five brands, and Ontario-based Aurora Cannabis (NYSE: ACB) was popular among customers. In March, the OCS' online store processed a record number of transactions due to stockpiling as a result of the COVID-19 outbreak. Dried flower was the la... | Aurora proving to be a dominant brand The OCS' report also broke down the top five brands, and Ontario-based Aurora Cannabis (NYSE: ACB) was popular among customers. In total, for the full fiscal year, the OCS website generated 71.4 million Canadian dollars while the government-run retail stores brought in CA$313.7 mil... | Aurora proving to be a dominant brand The OCS' report also broke down the top five brands, and Ontario-based Aurora Cannabis (NYSE: ACB) was popular among customers. In March, the OCS' online store processed a record number of transactions due to stockpiling as a result of the COVID-19 outbreak. During the first quarte... |
37422.0 | 2020-06-05 00:00:00 UTC | Aurora Cannabis (ACB): The Stock Is Too Hot on U.S. CBD Entry | ACB | https://www.nasdaq.com/articles/aurora-cannabis-acb%3A-the-stock-is-too-hot-on-u.s.-cbd-entry-2020-06-05 | nan | nan | In just a couple of weeks, Aurora Cannabis (ACB) has surged back to a rich valuation. The most recently news has the Canadian cannabis company entering the U.S. CBD space via an acquisition set to close in June.
The stock originally surged over 36% on the news leading to an increase in the stock value by over $500 mill... | Wall Street is not convinced that Aurora's reward is worth all the risk, especially when taking note that TipRanks analytics exhibit ACB as a Hold. In just a couple of weeks, Aurora Cannabis (ACB) has surged back to a rich valuation. Aurora Cannabis has cooled off some following the weak quarter from Canopy Growth, but... | In just a couple of weeks, Aurora Cannabis (ACB) has surged back to a rich valuation. Wall Street is not convinced that Aurora's reward is worth all the risk, especially when taking note that TipRanks analytics exhibit ACB as a Hold. The most recently news has the Canadian cannabis company entering the U.S. CBD space v... | In just a couple of weeks, Aurora Cannabis (ACB) has surged back to a rich valuation. Wall Street is not convinced that Aurora's reward is worth all the risk, especially when taking note that TipRanks analytics exhibit ACB as a Hold. U.S. CBD Deal Aurora Cannabis bought Reliva, LLC for $40 million in stock plus an earn... | In just a couple of weeks, Aurora Cannabis (ACB) has surged back to a rich valuation. Wall Street is not convinced that Aurora's reward is worth all the risk, especially when taking note that TipRanks analytics exhibit ACB as a Hold. The small deal allows Aurora Cannabis to enter the U.S. space without a large commitme... |
37423.0 | 2020-06-05 00:00:00 UTC | This Is the Biggest Problem in Canopy Growth's Q4 Earnings Report | ACB | https://www.nasdaq.com/articles/this-is-the-biggest-problem-in-canopy-growths-q4-earnings-report-2020-06-05 | nan | nan | Canopy Growth (NYSE: CGC) released its fourth-quarter results on May 29. The number that garnered attention was the company's mammoth loss, which totaled $1.3 billion Canadian dollars. It's another big loss from a company that's been no stranger to them in the past. And while that may be disappointing, there's a more t... | On the consumer side, it blamed the results on "expected off peak seasonal demand decline," as well as store closures amid the COVID-19 pandemic. But it's important to note that the online store also slashed many prices to offer more competitive products, which may have contributed to the surge while potentially divert... | Sales were down 13% from the third quarter In Q4, Canopy Growth reported net revenue of CA$107.9 million. That's in sharp contrast from the 76% sales growth that the pot producer generated during the full fiscal year. Why things may not get better anytime soon Since coming over from Constellation Brands (NYSE: STZ), wh... | Blaming COVID-19 for the drop in sales is a convenient excuse but shouldn't distract investors from the big question surrounding the company's ability to generate sales growth. Not only will COVID-19 create some new challenges this year, especially if a decline in the economy leads to fewer sales, but a significant cha... | That's in sharp contrast from the 76% sales growth that the pot producer generated during the full fiscal year. Why things may not get better anytime soon Since coming over from Constellation Brands (NYSE: STZ), which now owns 38.6% of Canopy Growth, new CEO David Klein has shifted the pot producer's focus from growth ... |
37424.0 | 2020-06-05 00:00:00 UTC | Aurora Cannabis To Sell Entire Stake In Alcanna | ACB | https://www.nasdaq.com/articles/aurora-cannabis-to-sell-entire-stake-in-alcanna-2020-06-05 | nan | nan | (RTTNews) - Canadian cannabis company Aurora Cannabis is selling its entire stake in Alcanna to an underwriting syndicate led by Cormark Securities Inc.
Canada-based Alcanna is one of the largest private sector retailers of alcohol in North America and the largest in Canada by number of stores, operating 231 locations ... | (RTTNews) - Canadian cannabis company Aurora Cannabis is selling its entire stake in Alcanna to an underwriting syndicate led by Cormark Securities Inc. Canada-based Alcanna is one of the largest private sector retailers of alcohol in North America and the largest in Canada by number of stores, operating 231 locations ... | (RTTNews) - Canadian cannabis company Aurora Cannabis is selling its entire stake in Alcanna to an underwriting syndicate led by Cormark Securities Inc. Canada-based Alcanna is one of the largest private sector retailers of alcohol in North America and the largest in Canada by number of stores, operating 231 locations ... | (RTTNews) - Canadian cannabis company Aurora Cannabis is selling its entire stake in Alcanna to an underwriting syndicate led by Cormark Securities Inc. Canada-based Alcanna is one of the largest private sector retailers of alcohol in North America and the largest in Canada by number of stores, operating 231 locations ... | Alcanna and Aurora Cannabis said they have entered into an agreement with a syndicate of underwriters led by Cormark Securities Inc., under which the underwriters will buy 9.2 million common shares of Alcanna currently held by Aurora Cannabis on a "bought deal" basis. The underwriting syndicate will purchase the shares... |
37425.0 | 2020-06-04 00:00:00 UTC | Aurora Cannabis Sells Out of Stake in Alcanna | ACB | https://www.nasdaq.com/articles/aurora-cannabis-sells-out-of-stake-in-alcanna-2020-06-05 | nan | nan | Aurora Cannabis (NYSE: ACB) is divesting a large asset. The company is selling the entirety of its 9.2 million share stake of common stock in fellow Canadian company Alcanna.
This will be effected in a "bought deal" arranged with an underwriting syndicate, at a price of three Canadian dollars ($2.22) per share. That sy... | Aurora Cannabis (NYSE: ACB) is divesting a large asset. According to a joint press release on the sale published by the marijuana company and Alcanna, the former's holding now comprises 23% of all issued and outstanding shares of the latter. Following Aurora's 2018 investment, Alcanna branched out into marijuana retail... | Aurora Cannabis (NYSE: ACB) is divesting a large asset. The company is selling the entirety of its 9.2 million share stake of common stock in fellow Canadian company Alcanna. All told, Aurora's sale should bring in around CA$27.6 million ($20.4 million) in gross proceeds, which represents a significant loss. | Aurora Cannabis (NYSE: ACB) is divesting a large asset. The company is selling the entirety of its 9.2 million share stake of common stock in fellow Canadian company Alcanna. According to a joint press release on the sale published by the marijuana company and Alcanna, the former's holding now comprises 23% of all issu... | Aurora Cannabis (NYSE: ACB) is divesting a large asset. The company is selling the entirety of its 9.2 million share stake of common stock in fellow Canadian company Alcanna. Following Aurora's 2018 investment, Alcanna branched out into marijuana retail, opening a chain of dispensaries called Nova Cannabis. |
37426.0 | 2020-06-04 00:00:00 UTC | Catalysts Remain in Play, but Canopy Growth Stock Remains a Hold for Now | ACB | https://www.nasdaq.com/articles/catalysts-remain-in-play-but-canopy-growth-stock-remains-a-hold-for-now-2020-06-04 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
What’s next for Canopy Growth (NYSE:CGC) stock? Shares in the pot stock tumbled after a disappointing earnings report May 29. But, despite tough times for the cannabis space in general, there could be good reason why shares may rebound in the near future.
S... | Add in Canopy’s clear edge against floundering rivals like Aurora Cannabis (NYSE:ACB), and you can make a bull case for this stock. The company remains a “work in progress.” Yet, with Constellation Brands (NYSE:STZ) taking de-facto control and spearheading a much-needed turnaround, fortunes could soon improve. As Inves... | Add in Canopy’s clear edge against floundering rivals like Aurora Cannabis (NYSE:ACB), and you can make a bull case for this stock. InvestorPlace - Stock Market News, Stock Advice & Trading Tips What’s next for Canopy Growth (NYSE:CGC) stock? Weighing the Bull Case Against the Bear Case, CGC Stock Remains a Hold The ne... | Add in Canopy’s clear edge against floundering rivals like Aurora Cannabis (NYSE:ACB), and you can make a bull case for this stock. InvestorPlace - Stock Market News, Stock Advice & Trading Tips What’s next for Canopy Growth (NYSE:CGC) stock? The analyst, a long-time CGC stock bull, recently downgraded shares from “buy... | Add in Canopy’s clear edge against floundering rivals like Aurora Cannabis (NYSE:ACB), and you can make a bull case for this stock. Granted, this does not guarantee pot legalization right away. If Constellation’s aggressive turnaround plan pays off, the company could be well on its way to profitability. |
37427.0 | 2020-06-04 00:00:00 UTC | Is Canopy Growth at Risk of Going Bankrupt? | ACB | https://www.nasdaq.com/articles/is-canopy-growth-at-risk-of-going-bankrupt-2020-06-04 | nan | nan | Cannabis companies have been reporting significant losses thanks in large part to widespread COVID-19 lockdowns. Canopy Growth (NYSE: CGC), one of the largest pot producers, startled investors last week when it reported a CA$1.3 billion net loss for its fiscal fourth quarter.
Although Canopy is known for being one of t... | Canopy Growth (NYSE: CGC), one of the largest pot producers, startled investors last week when it reported a CA$1.3 billion net loss for its fiscal fourth quarter. However, I don't think this uptick in revenue would be enough to completely mitigate the company's already significant operating expenses, let alone future ... | Canopy saw net losses jump to a staggering CA$1.3 billion, much lower than the CA$124.2 million net loss reported back in the previous quarter. Short-term investments, which can be sold quickly for cash, have also declined substantially from last year, down from CA$2.0 billion to just CA$673.3 million as of Q4 2020. $1... | Canopy Growth (NYSE: CGC), one of the largest pot producers, startled investors last week when it reported a CA$1.3 billion net loss for its fiscal fourth quarter. Canopy saw net losses jump to a staggering CA$1.3 billion, much lower than the CA$124.2 million net loss reported back in the previous quarter. In 2018, Con... | While this might seem alarming at first, just over half of this net loss, CA$743 million, is due to asset impairment and restructuring expenses. Short-term investments, which can be sold quickly for cash, have also declined substantially from last year, down from CA$2.0 billion to just CA$673.3 million as of Q4 2020. $... |
37428.0 | 2020-06-04 00:00:00 UTC | 3 Cannabis Stocks to Avoid Like the Plague in June | ACB | https://www.nasdaq.com/articles/3-cannabis-stocks-to-avoid-like-the-plague-in-june-2020-06-04 | nan | nan | For years, marijuana stocks were viewed by investors as the greatest thing since sliced bread. With the legal pot industry generating $10.9 billion in worldwide sales in 2018, and Wall Street suggesting that annual global sales could hit $50 billion to $200 billion by 2030, investors figured they had a surefire winner ... | Aurora Cannabis Although it was easily the hottest marijuana stock in May, and has consistently remained the most popular pot stock among millennial investors, I would strongly encourage investors not to put their money to work in Alberta-based Aurora Cannabis (NYSE: ACB). But Aurora's dreams have been shattered by reg... | Aurora Cannabis Although it was easily the hottest marijuana stock in May, and has consistently remained the most popular pot stock among millennial investors, I would strongly encourage investors not to put their money to work in Alberta-based Aurora Cannabis (NYSE: ACB). During its fiscal third quarter, MedMen dispos... | Aurora Cannabis Although it was easily the hottest marijuana stock in May, and has consistently remained the most popular pot stock among millennial investors, I would strongly encourage investors not to put their money to work in Alberta-based Aurora Cannabis (NYSE: ACB). During its fiscal third quarter, MedMen dispos... | Aurora Cannabis Although it was easily the hottest marijuana stock in May, and has consistently remained the most popular pot stock among millennial investors, I would strongly encourage investors not to put their money to work in Alberta-based Aurora Cannabis (NYSE: ACB). With the legal pot industry generating $10.9 b... |
37429.0 | 2020-06-03 00:00:00 UTC | Whether You Pay $14 or $1, Aurora Cannabis Still Has Some Major Weaknesses | ACB | https://www.nasdaq.com/articles/whether-you-pay-%2414-or-%241-aurora-cannabis-still-has-some-major-weaknesses-2020-06-03 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Aurora Cannabis (NASDAQ:ACB) recently did a reverse split on Aurora stock, consolidating 12 old shares into one new one. Instantly, its share price went from 62 cents a share to more than $7. As of June 3, the stock is above $14 a share.
Source: Shutterstoc... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurora Cannabis (NASDAQ:ACB) recently did a reverse split on Aurora stock, consolidating 12 old shares into one new one. 8 Battery Stocks That Will Seriously Power Your Portfolio At the time, I called Chesapeake a “dog with fleas,” harking back to the movie... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurora Cannabis (NASDAQ:ACB) recently did a reverse split on Aurora stock, consolidating 12 old shares into one new one. Aurora’s Cash Position At the end of March, Aurora had 230.2 million CAD in cash on its balance sheet, up from 156.3 million CAD at the ... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurora Cannabis (NASDAQ:ACB) recently did a reverse split on Aurora stock, consolidating 12 old shares into one new one. Aurora’s Cash Position At the end of March, Aurora had 230.2 million CAD in cash on its balance sheet, up from 156.3 million CAD at the ... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurora Cannabis (NASDAQ:ACB) recently did a reverse split on Aurora stock, consolidating 12 old shares into one new one. Most of that cash came from selling 11.7 million shares (based on the 12-for-1 reverse split) for net proceeds of 206.4 million CAD. Tha... |
37430.0 | 2020-06-03 00:00:00 UTC | Why Canopy Growth Is Still a Better Marijuana Stock Than Aurora Cannabis | ACB | https://www.nasdaq.com/articles/why-canopy-growth-is-still-a-better-marijuana-stock-than-aurora-cannabis-2020-06-03 | nan | nan | Aurora Cannabis (NYSE: ACB) surprised nearly everyone in mid-May with better-than-expected fiscal 2020 third-quarter results. The Canadian cannabis producer's sales soared, and so did its stock.
It was a much different story for Canopy Growth (NYSE: CGC) when the company reported its fiscal 2020 fourth-quarter update l... | Aurora Cannabis (NYSE: ACB) surprised nearly everyone in mid-May with better-than-expected fiscal 2020 third-quarter results. Booth went along with billionaire investor Nelson Peltz's idea that it would be better for Aurora to remain independent and only seek partners from outside the cannabis industry who didn't want ... | Aurora Cannabis (NYSE: ACB) surprised nearly everyone in mid-May with better-than-expected fiscal 2020 third-quarter results. The Canadian cannabis producer's sales soared, and so did its stock. An expectations advantage Stocks move up and down in large part due to how companies perform against expectations. | Aurora Cannabis (NYSE: ACB) surprised nearly everyone in mid-May with better-than-expected fiscal 2020 third-quarter results. Instead, here are three reasons why Canopy Growth is still a better marijuana stock to buy than Aurora Cannabis. Aurora CFO Glenn Ibbott said in the company's Q3 conference call that its cash po... | Aurora Cannabis (NYSE: ACB) surprised nearly everyone in mid-May with better-than-expected fiscal 2020 third-quarter results. My view is that Canopy's partnership with Constellation gives it a both a short-term and long-term advantage over Aurora. Better than Canopy Just because I think Canopy Growth is still better th... |
37431.0 | 2020-06-03 00:00:00 UTC | Approach Volatile Cannabis Producer Tilray Stock With Caution | ACB | https://www.nasdaq.com/articles/approach-volatile-cannabis-producer-tilray-stock-with-caution-2020-06-03 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Shares of cannabis producer Tilray (NASDAQ:TLRY) have been building solid gains in recent weeks, but investors should still approach this volatile stock with caution.
Source: Jarretera / Shutterstock.com
The price of the Canadian cannabis company’s stock ha... | Tilray and peers like Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB) suddenly became hot plays in an emerging new industry. While Tilray CEO Brendan Kennedy promised that the cannabis producer would achieve positive EBITDA by the fourth quarter of this year, several analysts downgraded their rating on TLRY sto... | Tilray and peers like Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB) suddenly became hot plays in an emerging new industry. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of cannabis producer Tilray (NASDAQ:TLRY) have been building solid gains in recent weeks, but investors should still ... | Tilray and peers like Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB) suddenly became hot plays in an emerging new industry. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of cannabis producer Tilray (NASDAQ:TLRY) have been building solid gains in recent weeks, but investors should still ... | Tilray and peers like Canopy Growth (NYSE:CGC) and Aurora Cannabis (NYSE:ACB) suddenly became hot plays in an emerging new industry. Data from federal agency Statistics Canada shows that, to date, the legal market for recreational cannabis has only supplanted 14% of the black market. Given the ongoing volatility of not... |
37432.0 | 2020-06-02 00:00:00 UTC | 1 Pot Stock That's a Hotter Buy Than Aurora and Canopy Growth | ACB | https://www.nasdaq.com/articles/1-pot-stock-thats-a-hotter-buy-than-aurora-and-canopy-growth-2020-06-02 | nan | nan | Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) are two of the biggest names in the cannabis industry today. And they're probably among the first names that come to mind when thinking of the industry, but that doesn't make them great buys. Both companies have struggled with profitability and growing their sal... | Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) are two of the biggest names in the cannabis industry today. Curaleaf's already ahead of the industry leaders in Canada in terms of sales, and what makes it an even more attractive buy is that it's continuing to expand into hotter markets. CEO Joseph Lusardi see... | Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) are two of the biggest names in the cannabis industry today. By comparison, Aurora generated just 75.5 million Canadian dollars in its third-quarter results, while Canopy Growth reported quarterly revenue of CA$107.9 million in the results it released on May 29t... | Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) are two of the biggest names in the cannabis industry today. On May 11, Curaleaf announced that it was partnering with Mango Cannabis, a company that owns medical marijuana dispensaries in Oklahoma and that will distribute Curaleaf's Select products there. CEO J... | Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) are two of the biggest names in the cannabis industry today. With Curaleaf expanding into some hot markets and already generating tremendous sales, it's in a good position to establish itself as the undisputed industry leader this year. Not only are its sales be... |
37433.0 | 2020-06-02 00:00:00 UTC | The 3 Must-Knows of Cannabis Stock Investing | ACB | https://www.nasdaq.com/articles/the-3-must-knows-of-cannabis-stock-investing-2020-06-02 | nan | nan | For years, there wasn't a hotter investment on Wall Street than cannabis stocks. Investors with the wherewithal and stomach to have invested in some of the most prominent pot stocks in 2016 or 2017 found themselves up, in some cases, by quadruple digits during the first quarter of 2019. In fact, more than a dozen pot s... | For instance, Aurora Cannabis (NYSE: ACB) has long been the most-popular pot stock, and is an absolute favorite among millennials. Some of these problems have manifested directly from the federal government, with Health Canada delaying the launch of high-margin derivatives (i.e., vapes, edibles, and infused beverages) ... | For instance, Aurora Cannabis (NYSE: ACB) has long been the most-popular pot stock, and is an absolute favorite among millennials. In 2017, and prior to Canada legalizing adult-use weed in October 2018, promises of aggressive capacity expansion were more than enough to keep investors excited about the industry. On the ... | For instance, Aurora Cannabis (NYSE: ACB) has long been the most-popular pot stock, and is an absolute favorite among millennials. In order to realize the fruits of what the cannabis industry has to offer investors, you need to be willing to hang onto your pot stocks for years (not days!) The U.S. is the best long-term... | For instance, Aurora Cannabis (NYSE: ACB) has long been the most-popular pot stock, and is an absolute favorite among millennials. For years, there wasn't a hotter investment on Wall Street than cannabis stocks. The U.S. is the best long-term play for investors The third must-know about cannabis stock investing is that... |
37434.0 | 2020-05-31 00:00:00 UTC | Aurora Cannabis Was the Hottest Big Marijuana Stock in May -- but Will Its Sizzle Soon Fizzle? | ACB | https://www.nasdaq.com/articles/aurora-cannabis-was-the-hottest-big-marijuana-stock-in-may-but-will-its-sizzle-soon-fizzle | nan | nan | It might not quite be summer officially yet, but several pot stocks are already hot. And only one of them with a market cap of greater than $500 million skyrocketed nearly 70% in May -- Aurora Cannabis (NYSE: ACB).
Aurora ranks as arguably the hottest big marijuana stock on the market right now. But could its sizzle s... | And only one of them with a market cap of greater than $500 million skyrocketed nearly 70% in May -- Aurora Cannabis (NYSE: ACB). The company's market cap has risen over 16 times more than its share price as a result of the massive stock dilution. However, interim CEO Michael Singer said in the company's Q3 call that t... | And only one of them with a market cap of greater than $500 million skyrocketed nearly 70% in May -- Aurora Cannabis (NYSE: ACB). The huge jump for Aurora's shares over the past two weeks looks like a classic short squeeze. The company's market cap has risen over 16 times more than its share price as a result of the ma... | And only one of them with a market cap of greater than $500 million skyrocketed nearly 70% in May -- Aurora Cannabis (NYSE: ACB). When Aurora beat expectations, it's a near-certainty that some of the short-sellers quickly moved to cover their losses by buying Aurora stock. The curse of rising expectations I couldn't th... | And only one of them with a market cap of greater than $500 million skyrocketed nearly 70% in May -- Aurora Cannabis (NYSE: ACB). The huge jump for Aurora's shares over the past two weeks looks like a classic short squeeze. Keep in mind, also, that positive adjusted EBITDA isn't true profitability. |
37435.0 | 2020-05-30 00:00:00 UTC | Better Marijuana Stock: Green Thumb Industries or Curaleaf? | ACB | https://www.nasdaq.com/articles/better-marijuana-stock%3A-green-thumb-industries-or-curaleaf-2020-05-30 | nan | nan | Marijuana is still federally illegal in the U.S. -- but that isn't stopping the industry from growing. Currently, 11 states plus Washington, D.C., have legalized recreational marijuana, while 33 states and D.C. have legalized medical use.
Canada legalized cannabis far before the U.S., making medical cannabis legal in 2... | Green Thumb: a rising cannabis star If you want to expand your business, you need strategies for how to do so while keeping your balance sheet strong -- bigger cannabis players such as Aurora Cannabis (NYSE: ACB) have failed to take this vital step. But Green Thumb Industries (OTC: GTBIF), with a market presence of 44 ... | Green Thumb: a rising cannabis star If you want to expand your business, you need strategies for how to do so while keeping your balance sheet strong -- bigger cannabis players such as Aurora Cannabis (NYSE: ACB) have failed to take this vital step. But Green Thumb Industries (OTC: GTBIF), with a market presence of 44 ... | Green Thumb: a rising cannabis star If you want to expand your business, you need strategies for how to do so while keeping your balance sheet strong -- bigger cannabis players such as Aurora Cannabis (NYSE: ACB) have failed to take this vital step. Positive profitability While most Canadian cannabis peers are struggli... | Green Thumb: a rising cannabis star If you want to expand your business, you need strategies for how to do so while keeping your balance sheet strong -- bigger cannabis players such as Aurora Cannabis (NYSE: ACB) have failed to take this vital step. Management at Curaleaf believes Illinois and Pennsylvania to be the fa... |
37436.0 | 2020-05-29 00:00:00 UTC | Why Aurora Cannabis Stock Dropped 10% This Morning | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-stock-dropped-10-this-morning-2020-05-29 | nan | nan | What happened
Canadian cannabis kingpin Aurora Cannabis (NYSE: ACB) closed its acquisition of Massachusetts-based cannabidiol (CBD) maker Reliva LLC last night in a $40 million deal (or more than twice that, if Reliva hits certain financial milestones over the next couple of years).
That sounds like good news, but inve... | What happened Canadian cannabis kingpin Aurora Cannabis (NYSE: ACB) closed its acquisition of Massachusetts-based cannabidiol (CBD) maker Reliva LLC last night in a $40 million deal (or more than twice that, if Reliva hits certain financial milestones over the next couple of years). Aurora Cannabis stock plunged more t... | What happened Canadian cannabis kingpin Aurora Cannabis (NYSE: ACB) closed its acquisition of Massachusetts-based cannabidiol (CBD) maker Reliva LLC last night in a $40 million deal (or more than twice that, if Reliva hits certain financial milestones over the next couple of years). Aurora Cannabis stock plunged more t... | What happened Canadian cannabis kingpin Aurora Cannabis (NYSE: ACB) closed its acquisition of Massachusetts-based cannabidiol (CBD) maker Reliva LLC last night in a $40 million deal (or more than twice that, if Reliva hits certain financial milestones over the next couple of years). If Aurora ends up paying the extra $... | What happened Canadian cannabis kingpin Aurora Cannabis (NYSE: ACB) closed its acquisition of Massachusetts-based cannabidiol (CBD) maker Reliva LLC last night in a $40 million deal (or more than twice that, if Reliva hits certain financial milestones over the next couple of years). At $40 million, the purchase price i... |
37437.0 | 2020-05-29 00:00:00 UTC | 3 of the Best Breakout Stocks to Buy Now | ACB | https://www.nasdaq.com/articles/3-of-the-best-breakout-stocks-to-buy-now-2020-05-29 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Stocks suffered a late-day rug pull on Thursday after our Tweeter-in-Chief announced he’d hold a news conference on U.S.-China relations. Uncertainty surrounding what the President will say had traders heading for the exits. The reality is stocks have been ... | Aurora Cannabis (ACB) Source: The thinkorswim® platform from TD Ameritrade After lying dormant for most of the year, cannabis stocks are all of a sudden hot. Of the three, ACB stock has the most attractive pattern right now. The basing is well-deserved after such a moonshot and is helping ACB stock work through overbou... | Aurora Cannabis (ACB) Source: The thinkorswim® platform from TD Ameritrade After lying dormant for most of the year, cannabis stocks are all of a sudden hot. Of the three, ACB stock has the most attractive pattern right now. The basing is well-deserved after such a moonshot and is helping ACB stock work through overbou... | Aurora Cannabis (ACB) Source: The thinkorswim® platform from TD Ameritrade After lying dormant for most of the year, cannabis stocks are all of a sudden hot. Of the three, ACB stock has the most attractive pattern right now. The basing is well-deserved after such a moonshot and is helping ACB stock work through overbou... | Aurora Cannabis (ACB) Source: The thinkorswim® platform from TD Ameritrade After lying dormant for most of the year, cannabis stocks are all of a sudden hot. Of the three, ACB stock has the most attractive pattern right now. The basing is well-deserved after such a moonshot and is helping ACB stock work through overbou... |
37438.0 | 2020-05-29 00:00:00 UTC | Aurora Cannabis Acquisition of Reliva Closes | ACB | https://www.nasdaq.com/articles/aurora-cannabis-acquisition-of-reliva-closes-2020-05-29 | nan | nan | Aurora Cannabis' (NYSE: ACB) latest asset buy is in the books. The company announced on Thursday that its purchase of Reliva, a maker of hemp-derived cannabidiol (CBD) products, has closed.
The news comes just over a week after Aurora divulged that it and Reliva had agreed to the acquisition. The basic terms of the dea... | Aurora Cannabis' (NYSE: ACB) latest asset buy is in the books. The company announced on Thursday that its purchase of Reliva, a maker of hemp-derived cannabidiol (CBD) products, has closed. The impetus behind the marijuana company's purchase is to gain a major CBD asset based in the huge U.S. market (Aurora is headquar... | Aurora Cannabis' (NYSE: ACB) latest asset buy is in the books. The impetus behind the marijuana company's purchase is to gain a major CBD asset based in the huge U.S. market (Aurora is headquartered in Canada). After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market. | Aurora Cannabis' (NYSE: ACB) latest asset buy is in the books. The basic terms of the deal are that Aurora is to pay $40 million in common stock for Reliva, with potentially as much as $45 million more if the latter hits certain financial incentives across the following two years. * David and Tom just revealed what the... | Aurora Cannabis' (NYSE: ACB) latest asset buy is in the books. The company announced on Thursday that its purchase of Reliva, a maker of hemp-derived cannabidiol (CBD) products, has closed. The company said Reliva's products are sold in more than 20,000 retail locations and online. |
37439.0 | 2020-05-29 00:00:00 UTC | Why Aurora's Expansion Into the U.S. Market Really Isn't All That Exciting | ACB | https://www.nasdaq.com/articles/why-auroras-expansion-into-the-u.s.-market-really-isnt-all-that-exciting-2020-05-29 | nan | nan | In recent weeks, Aurora Cannabis (NYSE: ACB) stock has seen new life. It all started with the company releasing its third-quarter 2020 results on May 14, which showed 18% revenue growth from the prior period. A commitment to further improving its costs also gave investors a reason to be hopeful that profitability may n... | In recent weeks, Aurora Cannabis (NYSE: ACB) stock has seen new life. In the company's first-quarter results, released on May 14, Charlotte's Web announced that its reach surpassed 11,000 locations and that its sales for the three-month period totaled $21.5 million. The pot stock is still down more than 80% over the pa... | In recent weeks, Aurora Cannabis (NYSE: ACB) stock has seen new life. And until the U.S. government legalizes medical or recreational marijuana, it's a limitation Canadian cannabis companies will face. Hemp-derived CBD company Charlotte's Web (OTC: CWBHF), sells its products in fewer locations, and it has far stronger ... | In recent weeks, Aurora Cannabis (NYSE: ACB) stock has seen new life. That's because Aurora will not only be competing with other U.S. companies for market share, but with Canadian pot stocks that are also looking to take advantage of the opportunities in the hemp market. Having access to thousands of locations doesn't... | In recent weeks, Aurora Cannabis (NYSE: ACB) stock has seen new life. That's because Aurora will not only be competing with other U.S. companies for market share, but with Canadian pot stocks that are also looking to take advantage of the opportunities in the hemp market. The increase in locations over the past year ha... |
37440.0 | 2020-05-28 00:00:00 UTC | Can Aurora Cannabis Recover in 2020? | ACB | https://www.nasdaq.com/articles/can-aurora-cannabis-recover-in-2020-2020-05-28 | nan | nan | So you think the cannabis sector has seen its worst? That there's no coming back? Well, here's a twist: The COVID-19 pandemic might have dragged down most sectors, but it is lifting up marijuana stocks for sure. Cannabis sales skyrocketed in April amid the pandemic, pushing companies' revenues higher. In fact, most mar... | A phoenix from the ashes Edmonton, Alberta-based Aurora Cannabis (NYSE: ACB) saw strong demand after Canada legalized recreational marijuana in 2018. Recently, Canopy Growth (NYSE: CGC) also announced the launch of its next batch of cannabis 2.0 products -- cannabis-infused beverages, chocolates, and vapes. What matter... | A phoenix from the ashes Edmonton, Alberta-based Aurora Cannabis (NYSE: ACB) saw strong demand after Canada legalized recreational marijuana in 2018. Q3 results can't hide the fact that despite rising revenues, Aurora reported negative EBITDA (earnings before interest, taxes, depreciation, and amortization) of CA$50.8 ... | A phoenix from the ashes Edmonton, Alberta-based Aurora Cannabis (NYSE: ACB) saw strong demand after Canada legalized recreational marijuana in 2018. Its Q3 consumer cannabis revenue was up 24% sequentially to CA$41.5 million; that included its Daily Special brand, launched in February, and a few of the cannabis 2.0 pr... | A phoenix from the ashes Edmonton, Alberta-based Aurora Cannabis (NYSE: ACB) saw strong demand after Canada legalized recreational marijuana in 2018. Well, here's a twist: The COVID-19 pandemic might have dragged down most sectors, but it is lifting up marijuana stocks for sure. It also reported sequential quarterly sa... |
37441.0 | 2020-05-28 00:00:00 UTC | COVID-19's Surprising Impact on Cannabis Sales | ACB | https://www.nasdaq.com/articles/covid-19s-surprising-impact-on-cannabis-sales-2020-05-28 | nan | nan | For the past couple of months, the coronavirus disease 2019 (COVID-19) pandemic has wreaked havoc on the U.S. and global economy. In the U.S., more than 39 million people have filed an initial jobless claim within the past nine weeks, while the unemployment rate in India has increased from 8.7% in March to more than 27... | For instance, Aurora Cannabis (NYSE: ACB) recently reported fiscal third-quarter results that knocked Wall Street's socks off. With Aurora's adult-use revenue jumping 24% from the sequential quarter to CA$41.5 million, there's little question that consumer stockpiling ahead of Canadian stay-at-home orders was driving a... | For instance, Aurora Cannabis (NYSE: ACB) recently reported fiscal third-quarter results that knocked Wall Street's socks off. Pot sales have soared in most states and throughout Canada during the COVID-19 pandemic On Friday, May 22, Health Canada released its latest retail trade sales figures, covering total sales for... | For instance, Aurora Cannabis (NYSE: ACB) recently reported fiscal third-quarter results that knocked Wall Street's socks off. Pot sales have soared in most states and throughout Canada during the COVID-19 pandemic On Friday, May 22, Health Canada released its latest retail trade sales figures, covering total sales for... | For instance, Aurora Cannabis (NYSE: ACB) recently reported fiscal third-quarter results that knocked Wall Street's socks off. But this hasn't been the case the marijuana industry. Pot sales have soared in most states and throughout Canada during the COVID-19 pandemic On Friday, May 22, Health Canada released its lates... |
37442.0 | 2020-05-28 00:00:00 UTC | OrganiGram Releases Cannabis 2.0 Products To Medical Users | ACB | https://www.nasdaq.com/articles/organigram-releases-cannabis-2.0-products-to-medical-users-2020-05-28 | nan | nan | Like many Canadian cannabis companies, OrganiGram (TSX: OGI) (NASDAQ: OGI) has had a tough year, losing 75% of its value over 12 months and having to dip into the markets to raise cash.
Growing pains associated with Canadian cannabis legalization plagued OrganiGram's once-promising roll out of regulated cannabis produc... | For instance, Aurora Cannabis (NYSE: ACB) released its competing product lines in January. Earlier this year, OrganiGram tested its preliminary shipments of derivative products to see how they were received among users. Because a game-changing deal just went down between the Ontario government and this powerhouse compa... | For instance, Aurora Cannabis (NYSE: ACB) released its competing product lines in January. Like many Canadian cannabis companies, OrganiGram (TSX: OGI) (NASDAQ: OGI) has had a tough year, losing 75% of its value over 12 months and having to dip into the markets to raise cash. The Motley Fool owns shares of and recommen... | For instance, Aurora Cannabis (NYSE: ACB) released its competing product lines in January. Growing pains associated with Canadian cannabis legalization plagued OrganiGram's once-promising roll out of regulated cannabis products. In January, the Canadian government began its cannabis 2.0 program in which derivative prod... | For instance, Aurora Cannabis (NYSE: ACB) released its competing product lines in January. In January, the Canadian government began its cannabis 2.0 program in which derivative products made from the marijuana plant can be legally sold in the form of an oil to be cooked into an edible product, used as a trans-dermal p... |
37443.0 | 2020-05-27 00:00:00 UTC | 10 Stocks Worth Your Time on Robinhood’s Top 100 List | ACB | https://www.nasdaq.com/articles/10-stocks-worth-your-time-on-robinhoods-top-100-list-2020-05-27 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Ford (NYSE:F)
Aurora (NYSE:ACB)
Bank of America (NYSE:BAC)
Plug Power (NASDAQ:PLUG)
Snap (NYSE:SNAP)
Canopy Growth (NYSE:CGC)
Facebook (NASDAQ:FB)
Nio (NYSE:NIO)
Square (NYSE:SQ)
Beyond Meat (NASDAQ:BYND)
Crowd wisdom provides invaluable insight into market... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ford (NYSE:F) Aurora (NYSE:ACB) Bank of America (NYSE:BAC) Plug Power (NASDAQ:PLUG) Snap (NYSE:SNAP) Canopy Growth (NYSE:CGC) Facebook (NASDAQ:FB) Nio (NYSE:NIO) Square (NYSE:SQ) Beyond Meat (NASDAQ:BYND) Crowd wisdom provides invaluable insight into market... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ford (NYSE:F) Aurora (NYSE:ACB) Bank of America (NYSE:BAC) Plug Power (NASDAQ:PLUG) Snap (NYSE:SNAP) Canopy Growth (NYSE:CGC) Facebook (NASDAQ:FB) Nio (NYSE:NIO) Square (NYSE:SQ) Beyond Meat (NASDAQ:BYND) Crowd wisdom provides invaluable insight into market... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ford (NYSE:F) Aurora (NYSE:ACB) Bank of America (NYSE:BAC) Plug Power (NASDAQ:PLUG) Snap (NYSE:SNAP) Canopy Growth (NYSE:CGC) Facebook (NASDAQ:FB) Nio (NYSE:NIO) Square (NYSE:SQ) Beyond Meat (NASDAQ:BYND) Crowd wisdom provides invaluable insight into market... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ford (NYSE:F) Aurora (NYSE:ACB) Bank of America (NYSE:BAC) Plug Power (NASDAQ:PLUG) Snap (NYSE:SNAP) Canopy Growth (NYSE:CGC) Facebook (NASDAQ:FB) Nio (NYSE:NIO) Square (NYSE:SQ) Beyond Meat (NASDAQ:BYND) Crowd wisdom provides invaluable insight into market... |
37444.0 | 2020-05-27 00:00:00 UTC | Expect Canopy Growth Stock to Pass Its Big Earnings Test | ACB | https://www.nasdaq.com/articles/expect-canopy-growth-stock-to-pass-its-big-earnings-test-2020-05-27 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Cannabis stocks have caught a bounce, and Canopy Growth (NYSE:CGC) has been one of the beneficiaries. CGC stock now has doubled from March lows.
Source: Shutterstock
It’s not alone. The ETFMG Alternative Harvest ETF (NYSEARCA:MJ), which I use as a barometer... | That was followed by the biggest report of late in the sector: a strong fiscal third-quarter report from Aurora Cannabis (NYSE:ACB). ACB stock soared 69% on the news: it has now gained 170% in less than two weeks. 7 Cheap Stocks to Buy With Great Potential Simply put, Canopy Growth on Friday can keep the sector’s rally... | That was followed by the biggest report of late in the sector: a strong fiscal third-quarter report from Aurora Cannabis (NYSE:ACB). ACB stock soared 69% on the news: it has now gained 170% in less than two weeks. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cannabis stocks have caught a bounce, and C... | That was followed by the biggest report of late in the sector: a strong fiscal third-quarter report from Aurora Cannabis (NYSE:ACB). ACB stock soared 69% on the news: it has now gained 170% in less than two weeks. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cannabis stocks have caught a bounce, and C... | That was followed by the biggest report of late in the sector: a strong fiscal third-quarter report from Aurora Cannabis (NYSE:ACB). ACB stock soared 69% on the news: it has now gained 170% in less than two weeks. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cannabis stocks have caught a bounce, and C... |
37445.0 | 2020-05-27 00:00:00 UTC | Aurora Stock Is a Contentious Contrarian Cannabis Play | ACB | https://www.nasdaq.com/articles/aurora-stock-is-a-contentious-contrarian-cannabis-play-2020-05-27 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Sputtering from $100 a share to $6 within the span of a year, Aurora Cannabis (NYSE:ACB) stock tested the resolve of investors. Then came the month of May, and a price-action roller-coaster ride ensued.
Source: Shutterstock
Daily moves of 20% or more were n... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sputtering from $100 a share to $6 within the span of a year, Aurora Cannabis (NYSE:ACB) stock tested the resolve of investors. 25 Stocks to Buy for the Reopening Rally After the unexpected resignation of Aurora Cannabis founder Terry Booth from the company... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sputtering from $100 a share to $6 within the span of a year, Aurora Cannabis (NYSE:ACB) stock tested the resolve of investors. Analysts expected revenues of CA$66.7 million while the actual result was CA$75.5 million. Quarterly revenues of CA$75.5 million ... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sputtering from $100 a share to $6 within the span of a year, Aurora Cannabis (NYSE:ACB) stock tested the resolve of investors. In fact, analyst firm Jefferies recently downgraded the stock from “hold” to “underperform.” At the same time, however, Jefferies... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sputtering from $100 a share to $6 within the span of a year, Aurora Cannabis (NYSE:ACB) stock tested the resolve of investors. That’s unsustainable for a company with overhead costs of around CA$100 million. Analysts expected revenues of CA$66.7 million wh... |
37446.0 | 2020-05-27 00:00:00 UTC | Don't Believe Aurora Cannabis' Profitability Spin | ACB | https://www.nasdaq.com/articles/dont-believe-aurora-cannabis-profitability-spin-2020-05-27 | nan | nan | Aurora Cannabis (NYSE: ACB) finally made the move that investors have anxiously awaited for a long time. The Canadian cannabis producer announced last week that it entered into an agreement to buy Reliva, which boasts one of the top-selling CBD brands in the U.S. market.
Investors cheered the news that Aurora will soo... | Aurora Cannabis (NYSE: ACB) finally made the move that investors have anxiously awaited for a long time. What we do know is that Aurora's press release announcing the acquisition stated that Reliva was profitable (with no caveats or clarifications) and that it took a follow-up interview for investors to learn the rest ... | Aurora Cannabis (NYSE: ACB) finally made the move that investors have anxiously awaited for a long time. Several of the company's top rivals, including Canopy Growth and Cronos Group, already have a presence in the U.S. Aurora stated that Reliva is "profitable today" and will provide the company with a top hemp CBD bra... | Aurora Cannabis (NYSE: ACB) finally made the move that investors have anxiously awaited for a long time. Several of the company's top rivals, including Canopy Growth and Cronos Group, already have a presence in the U.S. Aurora stated that Reliva is "profitable today" and will provide the company with a top hemp CBD bra... | Aurora Cannabis (NYSE: ACB) finally made the move that investors have anxiously awaited for a long time. But don't believe Aurora Cannabis' profitability spin. He stated that these moves will "fuel profitability" for Aurora. |
37447.0 | 2020-05-26 00:00:00 UTC | Weekly Cannabis Stock News: Aurora Cannabis Gets Back in the Acquisition Game | ACB | https://www.nasdaq.com/articles/weekly-cannabis-stock-news%3A-aurora-cannabis-gets-back-in-the-acquisition-game-2020-05-27 | nan | nan | Not long ago, previously acquisition-happy marijuana companies put the brakes on spending. Collectively, they lost money much more frequently than they made it -- so snapping up new assets to build scale became a less hot idea than it had been a few years ago.
That was then, and this is now. Last week's big cannabis co... | Last week's big cannabis company news was a throwback to the good old days of 2018 or so, with Aurora Cannabis (NYSE: ACB) signing on the dotted line for a buyout. Aurora said it expects Reliva to be "immediately accretive" in terms of every marijuana company's preferred operational metric -- adjusted EBITDA. And in mo... | Last week's big cannabis company news was a throwback to the good old days of 2018 or so, with Aurora Cannabis (NYSE: ACB) signing on the dotted line for a buyout. Another key pot industry event transpiring last week came when a major dispensary operator reporting its latest set of earnings. Its annual revenue is $13 m... | Last week's big cannabis company news was a throwback to the good old days of 2018 or so, with Aurora Cannabis (NYSE: ACB) signing on the dotted line for a buyout. It announced it has agreed to buy U.S. hemp-derived cannabidiol (CBD) products maker Reliva in a deal for roughly $40 million in Aurora common stock, plus u... | Last week's big cannabis company news was a throwback to the good old days of 2018 or so, with Aurora Cannabis (NYSE: ACB) signing on the dotted line for a buyout. It announced it has agreed to buy U.S. hemp-derived cannabidiol (CBD) products maker Reliva in a deal for roughly $40 million in Aurora common stock, plus u... |
37448.0 | 2020-05-26 00:00:00 UTC | 7 Marijuana Stocks to Watch as the Presidential Election Approaches | ACB | https://www.nasdaq.com/articles/7-marijuana-stocks-to-watch-as-the-presidential-election-approaches-2020-05-26 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
When a slew of cannabis firms reported quarterly earnings results, investors realized that markets beat down the sector. The sharp rally that ensued suggests that investors may continue holding or starting a new position in many marijuana stocks.
Not only a... | Interim CEO Michael Singer also said that “we are pleased with today’s announcement that Ontario retail stores with outside entrances will be allowed to reopen fully as soon as next week.” Plus, the dynamic consumer environment and potential in medical cannabis may give ACB stock a sustained uptrend. Here are the seven... | Here are the seven marijuana stocks that investors should watch as the presidential election approaches: Aurora Cannabis (NYSE:ACB) Aphria Inc. (NYSE:APHA) Canopy Growth (NYSE:CGC) Cronos Group (NASDAQ:CRON) Tilray (NASDAQ:TLRY) Curaleaf Holdings (OTCMKTS:CURLF) Hexo Corp (NYSE:HEXO) Aurora Cannabis (ACB) Source: Shutt... | Here are the seven marijuana stocks that investors should watch as the presidential election approaches: Aurora Cannabis (NYSE:ACB) Aphria Inc. (NYSE:APHA) Canopy Growth (NYSE:CGC) Cronos Group (NASDAQ:CRON) Tilray (NASDAQ:TLRY) Curaleaf Holdings (OTCMKTS:CURLF) Hexo Corp (NYSE:HEXO) Aurora Cannabis (ACB) Source: Shutt... | Here are the seven marijuana stocks that investors should watch as the presidential election approaches: Aurora Cannabis (NYSE:ACB) Aphria Inc. (NYSE:APHA) Canopy Growth (NYSE:CGC) Cronos Group (NASDAQ:CRON) Tilray (NASDAQ:TLRY) Curaleaf Holdings (OTCMKTS:CURLF) Hexo Corp (NYSE:HEXO) Aurora Cannabis (ACB) Source: Shutt... |
37449.0 | 2020-05-26 00:00:00 UTC | Why Aurora Cannabis (ACB) Stock Looks Attractive | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-acb-stock-looks-attractive-2020-05-26 | nan | nan | Aurora Cannabis (ACB) announced it has made a big move into the U.S. market via its acquisition of Reliva, LLC, one of the major players in America.
The company said the at close the deal will be "immediately accretive to shareholders on an adjusted EBITDA basis."
In this article we'll look at some of the strengths the... | Aurora Cannabis (ACB) announced it has made a big move into the U.S. market via its acquisition of Reliva, LLC, one of the major players in America. The members could receive up to US$45 million in earn-out in Aurora shares, cash, or a combination of the two, if Reliva reaches specific financial targets over the next t... | Aurora Cannabis (ACB) announced it has made a big move into the U.S. market via its acquisition of Reliva, LLC, one of the major players in America. Per terms of the deal, Reliva members will receive about US$40 million of Aurora common shares. Being able to leverage Reliva's CBD products across those various markets s... | Aurora Cannabis (ACB) announced it has made a big move into the U.S. market via its acquisition of Reliva, LLC, one of the major players in America. This aligns nicely with Aurora's goal of reaching adjusted EBITDA profitability in the first fiscal quarter of 2021, with expectations the deal will be accretive to Aurora... | Aurora Cannabis (ACB) announced it has made a big move into the U.S. market via its acquisition of Reliva, LLC, one of the major players in America. At this time Reliva sells its CBD brands in over 20,000 retail locations spread across the U.S. Also, as of March 2019, Reliva has generated positive EBITDA over the prior... |
37450.0 | 2020-05-26 00:00:00 UTC | Aurora Cannabis' Exeter Sale Confirms the Need for Industrywide Writedowns | ACB | https://www.nasdaq.com/articles/aurora-cannabis-exeter-sale-confirms-the-need-for-industrywide-writedowns-2020-05-26 | nan | nan | It's truly incredible what a difference a year has made in the North American cannabis industry. Throughout most of 2018 and the first quarter of 2019, pot stocks were pretty much unstoppable. Sales growth expectations were through the roof, and Canada had recently become the first industrialized country in the modern ... | This 180 in marijuana stocks has been especially noticeable for the most popular pot stock in the world, Aurora Cannabis (NYSE: ACB). It's been my contention recently that Aurora, which boasts CA$4.72 billion in total assets, will have little choice but to take significant writedowns on its goodwill, inventory, and pro... | This 180 in marijuana stocks has been especially noticeable for the most popular pot stock in the world, Aurora Cannabis (NYSE: ACB). This essentially means that Aurora paid CA$2.64 billion to acquire 35,000 kilos of annual output and MedReleaf's brands -- and a quick look at Canadian licensed producers shows that 35,0... | This 180 in marijuana stocks has been especially noticeable for the most popular pot stock in the world, Aurora Cannabis (NYSE: ACB). Aurora Cannabis' painful fall from grace At this time last year, Aurora Cannabis was forecast to be the leading global cannabis producer, with its 15 properties capable of producing more... | This 180 in marijuana stocks has been especially noticeable for the most popular pot stock in the world, Aurora Cannabis (NYSE: ACB). Aurora Cannabis' painful fall from grace At this time last year, Aurora Cannabis was forecast to be the leading global cannabis producer, with its 15 properties capable of producing more... |
37451.0 | 2020-05-26 00:00:00 UTC | Don’t Buy Aurora Stock Just Yet | ACB | https://www.nasdaq.com/articles/dont-buy-aurora-stock-just-yet-2020-05-26 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Last week was a big one for Aurora Cannabis (NYSE:ACB), to say the least. Aurora stock soared after the company reported a big earnings beat on May 14. Just days later on May 20, the company announced a buyout deal for U.S. CBD retailer Reliva.
Source: Shut... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Last week was a big one for Aurora Cannabis (NYSE:ACB), to say the least. 7 Excellent Penny Stocks Ready to Roar But Aurora said it remains on track to report positive earnings before interest, taxes, depreciation and amortization (EBITDA) by the fiscal fir... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Last week was a big one for Aurora Cannabis (NYSE:ACB), to say the least. Aurora stock soared after the company reported a big earnings beat on May 14. How to Play Aurora Stock Given the crazy price action in Aurora stock in the past week, investors are lik... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Last week was a big one for Aurora Cannabis (NYSE:ACB), to say the least. The Earnings Numbers for Aurora Stock First, let’s take a look at what was so good about Aurora’s earnings. The Reliva Deal In addition to the positive commentary on profitability and... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips Last week was a big one for Aurora Cannabis (NYSE:ACB), to say the least. However, in a follow-up to the positive earnings report, Aurora just announced it is entering the U.S. CBD market with a buyout of Reliva. How to Play Aurora Stock Given the crazy pri... |
37452.0 | 2020-05-24 00:00:00 UTC | Tilray's CEO Expects at Least a Dozen Cannabis Bankruptcies in 2020 -- Is He Right? | ACB | https://www.nasdaq.com/articles/tilrays-ceo-expects-at-least-a-dozen-cannabis-bankruptcies-in-2020-is-he-right-2020-05-24 | nan | nan | There's a lot of doom and gloom in the cannabis industry. It's hard to avoid when even the Horizons Marijuana Life Sciences ETF (OTC: HMLSF) has crashed 65% in the past year. Many cannabis companies have continued to struggle to stay out of the red even amid rapid growth. In the past that was fine, because their share ... | In February, investment bank Ello Capital estimated that pot giant Aurora Cannabis (NYSE: ACB) had just a couple of months' worth of liquidity at its disposal. Green Growth is most well known for making a $2.1 billion bid for Aphria (NYSE: ACB) in late 2018. Companies such as Canopy Growth (NYSE: CGC) and Cronos Group ... | In February, investment bank Ello Capital estimated that pot giant Aurora Cannabis (NYSE: ACB) had just a couple of months' worth of liquidity at its disposal. Green Growth is most well known for making a $2.1 billion bid for Aphria (NYSE: ACB) in late 2018. Canadian cannabis company Tilray's (NASDAQ: TLRY) CEO believe... | Green Growth is most well known for making a $2.1 billion bid for Aphria (NYSE: ACB) in late 2018. In February, investment bank Ello Capital estimated that pot giant Aurora Cannabis (NYSE: ACB) had just a couple of months' worth of liquidity at its disposal. Canadian cannabis company Tilray's (NASDAQ: TLRY) CEO believe... | Green Growth is most well known for making a $2.1 billion bid for Aphria (NYSE: ACB) in late 2018. In February, investment bank Ello Capital estimated that pot giant Aurora Cannabis (NYSE: ACB) had just a couple of months' worth of liquidity at its disposal. Should investors be getting out of the cannabis industry? |
37453.0 | 2020-05-24 00:00:00 UTC | Is Aurora Cannabis a Buy After Its Q3 Results? | ACB | https://www.nasdaq.com/articles/is-aurora-cannabis-a-buy-after-its-q3-results-2020-05-24 | nan | nan | Shares of Aurora Cannabis (NYSE: ACB) have been trading wildly since the cannabis producer released its third-quarter results May 14. The report was an encouraging one for investors, as Aurora made progress in sales and in bringing down its expenses from the previous quarter. But that doesn't mean there are no problems... | Shares of Aurora Cannabis (NYSE: ACB) have been trading wildly since the cannabis producer released its third-quarter results May 14. The company's management discussion and analysis (MD&A) noted that the biggest reason for the improvement was a CA$7.6 million reduction in net returns and adjustments. Aurora still has ... | Shares of Aurora Cannabis (NYSE: ACB) have been trading wildly since the cannabis producer released its third-quarter results May 14. And indeed, with CA$75.5 million in net revenue during Q3, Aurora showed a lot more than just modest growth. Sales are flat from Q1, when Aurora recorded CA$75.2 million in revenue; unre... | Shares of Aurora Cannabis (NYSE: ACB) have been trading wildly since the cannabis producer released its third-quarter results May 14. It was also an improvement from the CA$160.2 million loss Aurora incurred in the third quarter of fiscal 2019. Sales are flat from Q1, when Aurora recorded CA$75.2 million in revenue; un... | Shares of Aurora Cannabis (NYSE: ACB) have been trading wildly since the cannabis producer released its third-quarter results May 14. It was also an improvement from the CA$160.2 million loss Aurora incurred in the third quarter of fiscal 2019. And while Aurora did make improvements from the previous quarter, investors... |
37454.0 | 2020-05-23 00:00:00 UTC | Better Marijuana Stock: Aurora Cannabis vs. Cronos Group | ACB | https://www.nasdaq.com/articles/better-marijuana-stock%3A-aurora-cannabis-vs.-cronos-group-2020-05-23 | nan | nan | Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. You might think that after this huge gain, Aurora is outperforming rival Cronos Group (NASDAQ: CRON), which posted Q1 result... | Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. You might think that after this huge gain, Aurora is outperforming rival Cronos Group (NASDAQ: CRON), which posted Q1 result... | Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. The case for Aurora Cannabis Aurora's surprisingly positive Q3 results underscore the potential for the company. Early last ... | Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. The case for Aurora Cannabis Aurora's surprisingly positive Q3 results underscore the potential for the company. The case fo... | Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. Early last year, Altria invested $1.8 billion in Cronos, gaining a 45% stake in the cannabis producer. The deal gave Cronos ... |
37455.0 | 2020-05-23 00:00:00 UTC | Why Is Everyone Talking About Aurora Cannabis? | ACB | https://www.nasdaq.com/articles/why-is-everyone-talking-about-aurora-cannabis-2020-05-23 | nan | nan | The COVID-19 pandemic has been wreaking havoc on the economy for the better part of three months. As a result, many investors are increasingly looking for stability in a volatile stock market. And since most cannabis companies aren't consistently profitable -- and typically don't have anything resembling a timeline for... | One cannabis company that has been making a lot of noise over the past couple of weeks or so is none other than Aurora Cannabis (NYSE: ACB). Year to date, the Horizons Marijuana Life Sciences ETF (OTC: HMLSF) -- a benchmark for the cannabis industry -- is down by almost 20%, while the S&P 500 is only down by 8%. And wi... | One cannabis company that has been making a lot of noise over the past couple of weeks or so is none other than Aurora Cannabis (NYSE: ACB). Aurora Cannabis conducts a reverse stock split Aurora posted a string of poor financial performances last year and earlier in 2020. Aurora Cannabis's third-quarter financial resul... | One cannabis company that has been making a lot of noise over the past couple of weeks or so is none other than Aurora Cannabis (NYSE: ACB). As a result of these headwinds, Aurora's stock fell below $1 a share, and the company was at risk of being delisted from the New York Stock Exchange. Aurora Cannabis's third-quart... | One cannabis company that has been making a lot of noise over the past couple of weeks or so is none other than Aurora Cannabis (NYSE: ACB). Here are a few key figures to consider from Aurora's latest earnings report: Aurora sold 12,729 kilograms of cannabis during its third quarter, a 34% increase compared with the se... |
37456.0 | 2020-05-23 00:00:00 UTC | Could Aurora Cannabis Turn Its Q3 Success Into Long-Term Growth? | ACB | https://www.nasdaq.com/articles/could-aurora-cannabis-turn-its-q3-success-into-long-term-growth-2020-05-23 | nan | nan | Aurora Cannabis's (NYSE: ACB) stock has been wildly fluctuating since the release of its better-than-expected Q3 earnings report May 14 in which the company acknowledged $53.8 million in sales. First, Aurora's stock had an unusually strong day, surging upwards of 70% on Monday. Then, as quickly as traders piled on, the... | Aurora Cannabis's (NYSE: ACB) stock has been wildly fluctuating since the release of its better-than-expected Q3 earnings report May 14 in which the company acknowledged $53.8 million in sales. Despite industrial-scale manufacturing and highly efficient retail operations, Aurora is having difficulty selling its marijua... | Aurora Cannabis's (NYSE: ACB) stock has been wildly fluctuating since the release of its better-than-expected Q3 earnings report May 14 in which the company acknowledged $53.8 million in sales. Image source: Getty Images Even if Aurora beat analyst expectations in Q3, it's still trending downward Despite being a major ... | Aurora Cannabis's (NYSE: ACB) stock has been wildly fluctuating since the release of its better-than-expected Q3 earnings report May 14 in which the company acknowledged $53.8 million in sales. Image source: Getty Images Even if Aurora beat analyst expectations in Q3, it's still trending downward Despite being a major ... | Aurora Cannabis's (NYSE: ACB) stock has been wildly fluctuating since the release of its better-than-expected Q3 earnings report May 14 in which the company acknowledged $53.8 million in sales. More importantly, Aurora's cost of revenue has increased by more than 11 times since 2018. If management trims operations sign... |
37457.0 | 2020-05-22 00:00:00 UTC | TSX falls as oil weakens, Sino-U.S. tensions rise | ACB | https://www.nasdaq.com/articles/tsx-falls-as-oil-weakens-sino-u.s.-tensions-rise-2020-05-22 | nan | nan | May 22 (Reuters) - Canada's main stock index was dragged down by energy stocks on Friday, as oil prices fell and tensions between the United States and China rose.
* At 9:44 a.m. ET (13:43 GMT), the Toronto Stock Exchange's S&P/TSX composite index .GSPTSE was down 25.83 points, or 0.17%, at 14,859.02.
* The nation's do... | * The nation's domestic retail sales fell a record 10% in March as many non-essential businesses were shut down to curb the spread of the COVID-19 pandemic, Statistics Canada said on Friday, and also warned that April data could reveal an even sharper decline. * The materials sector .GSPTTMT, which includes precious an... | May 22 (Reuters) - Canada's main stock index was dragged down by energy stocks on Friday, as oil prices fell and tensions between the United States and China rose. * The energy sector .SPTTEN dropped 2.2% as U.S. crude CLc1 prices fell 3.0% a barrel, while Brent crude LCOc1 lost 3.1%. GOL/ * On the TSX, 77 issues were ... | May 22 (Reuters) - Canada's main stock index was dragged down by energy stocks on Friday, as oil prices fell and tensions between the United States and China rose. GOL/ * On the TSX, 77 issues were higher, while 143 issues declined for a 1.86-to-1 ratio in favor of the losers, with 26.60 million shares traded. * Aurora... | May 22 (Reuters) - Canada's main stock index was dragged down by energy stocks on Friday, as oil prices fell and tensions between the United States and China rose. O/R * The financials sector .SPTTFS slipped 1.1%, while industrial stocks .GSPTTIN rose 0.2%. * Across all Canadian issues, there were nine new 52-week high... |
37458.0 | 2020-05-22 00:00:00 UTC | Why Aurora Cannabis Stock Dropped on Friday | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-stock-dropped-on-friday-2020-05-22 | nan | nan | What happened
Shares of Aurora Cannabis (NYSE: ACB) sank 6.6% on Friday after analysts at Jefferies downgraded the popular marijuana stock.
So what
Jefferies lowered its rating on Aurora's stock from hold to underperform. The investment bank says the recent surge in Aurora's share price is too much, too fast.
"We thi... | What happened Shares of Aurora Cannabis (NYSE: ACB) sank 6.6% on Friday after analysts at Jefferies downgraded the popular marijuana stock. "We think near-term sales and [gross margin] headwinds are not fully appreciated, while celebrating a hiatus on further dilution is shortsighted," Jefferies analyst Owen Bennett sa... | What happened Shares of Aurora Cannabis (NYSE: ACB) sank 6.6% on Friday after analysts at Jefferies downgraded the popular marijuana stock. Aurora Cannabis gave back some of its recent stock price gains on Friday, following cautionary comments from Jefferies analyst Owen Bennett. After all, the newsletter they have run... | What happened Shares of Aurora Cannabis (NYSE: ACB) sank 6.6% on Friday after analysts at Jefferies downgraded the popular marijuana stock. Aurora Cannabis gave back some of its recent stock price gains on Friday, following cautionary comments from Jefferies analyst Owen Bennett. Bennett's new $10 target price represen... | What happened Shares of Aurora Cannabis (NYSE: ACB) sank 6.6% on Friday after analysts at Jefferies downgraded the popular marijuana stock. Aurora Cannabis gave back some of its recent stock price gains on Friday, following cautionary comments from Jefferies analyst Owen Bennett. After all, the newsletter they have run... |
37459.0 | 2020-05-22 00:00:00 UTC | TSX rises 0.19% to 14,913.64 | ACB | https://www.nasdaq.com/articles/tsx-rises-0.19-to-14913.64-2020-05-22 | nan | nan | * The Toronto Stock Exchange's TSX rises 0.19 percent to 14,913.64
* Leading the index were Hexo Corp , up 20.6%, Cronos Group Inc CRON.TO, up 8.5%, and Canopy Growth Corp WEED.TO, higher by 6.7%.
* Lagging shares were Aurora Cannabis Inc ACB.TO, down 6.7%, Mullen Group Ltd MTL.TO, down 5.8%, and CAE Inc CAE.TO, lower ... | * Lagging shares were Aurora Cannabis Inc ACB.TO, down 6.7%, Mullen Group Ltd MTL.TO, down 5.8%, and CAE Inc CAE.TO, lower by 5.6%. * On the TSX 109 issues rose and 118 fell as a 0.9-to-1 ratio favored decliners. * West Texas Intermediate crude futures CLc1 fell 1.06%, or $0.36, to $33.56 a barrel. | * Lagging shares were Aurora Cannabis Inc ACB.TO, down 6.7%, Mullen Group Ltd MTL.TO, down 5.8%, and CAE Inc CAE.TO, lower by 5.6%. * The Toronto Stock Exchange's TSX rises 0.19 percent to 14,913.64 * Leading the index were Hexo Corp , up 20.6%, Cronos Group Inc CRON.TO, up 8.5%, and Canopy Growth Corp WEED.TO, higher ... | * Lagging shares were Aurora Cannabis Inc ACB.TO, down 6.7%, Mullen Group Ltd MTL.TO, down 5.8%, and CAE Inc CAE.TO, lower by 5.6%. * The Toronto Stock Exchange's TSX rises 0.19 percent to 14,913.64 * Leading the index were Hexo Corp , up 20.6%, Cronos Group Inc CRON.TO, up 8.5%, and Canopy Growth Corp WEED.TO, higher ... | * Lagging shares were Aurora Cannabis Inc ACB.TO, down 6.7%, Mullen Group Ltd MTL.TO, down 5.8%, and CAE Inc CAE.TO, lower by 5.6%. * On the TSX 109 issues rose and 118 fell as a 0.9-to-1 ratio favored decliners. * The most heavily traded shares by volume were Hexo Corp HEXO.TO, Manulife Financial Corp MFC.TO and Bomba... |
37460.0 | 2020-05-22 00:00:00 UTC | BUZZ-U.S. STOCKS ON THE MOVE-LiveRamp, T2 Biosystems, Foot locker | ACB | https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-liveramp-t2-biosystems-foot-locker-2020-05-22 | nan | nan | Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
U.S. stock indexes moved in a flat-to-low range on Friday as investors gauged Sino-U.S. tensions amid continued uncertainty over the pace of economic recove... | The top three S&P 500 .PG.INX percentage gainers: ** Coty Inc , up 11.4% ** Harley-Davidson Inc , up 5.7% ** American Tower Corp , up 5.2% The top three S&P 500 .PL.INX percentage losers: ** Hewlett Packard Enterprise Co , down 10.8% ** Wynn Resorts Ltd , down 6.3% ** Alaska Air Group Inc , down 4.1% The top three NYSE... | The top three S&P 500 .PG.INX percentage gainers: ** Coty Inc , up 11.4% ** Harley-Davidson Inc , up 5.7% ** American Tower Corp , up 5.2% The top three S&P 500 .PL.INX percentage losers: ** Hewlett Packard Enterprise Co , down 10.8% ** Wynn Resorts Ltd , down 6.3% ** Alaska Air Group Inc , down 4.1% The top three NYSE... | The top three S&P 500 .PG.INX percentage gainers: ** Coty Inc , up 11.4% ** Harley-Davidson Inc , up 5.7% ** American Tower Corp , up 5.2% The top three S&P 500 .PL.INX percentage losers: ** Hewlett Packard Enterprise Co , down 10.8% ** Wynn Resorts Ltd , down 6.3% ** Alaska Air Group Inc , down 4.1% The top three NYSE... | The top three S&P 500 .PG.INX percentage gainers: ** Coty Inc , up 11.4% ** Harley-Davidson Inc , up 5.7% ** American Tower Corp , up 5.2% The top three S&P 500 .PL.INX percentage losers: ** Hewlett Packard Enterprise Co , down 10.8% ** Wynn Resorts Ltd , down 6.3% ** Alaska Air Group Inc , down 4.1% The top three NYSE... |
37461.0 | 2020-05-22 00:00:00 UTC | BUZZ-U.S. STOCKS ON THE MOVE-Abbott, Tetraphase Pharma, HPE | ACB | https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-abbott-tetraphase-pharma-hpe-2020-05-22 | nan | nan | Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
U.S. stock indexes moved in a flat-to-low range on Friday as simmering Sino-U.S. tensions weighed on markets struggling to gauge the pace of economic recove... | The top three S&P 500 .PG.INX percentage gainers: ** Coty Inc , up 6.3% ** Agilent Technologies Inc , up 5.9% ** American Tower Corp , up 4.9% The top three S&P 500 .PL.INX percentage losers: ** Hewlett Packard Enterprise Co , down 12.1% ** Wynn Resorts Ltd , down 6% ** State Street Corp , down 5.5% The top three NYSE ... | The top three S&P 500 .PG.INX percentage gainers: ** Coty Inc , up 6.3% ** Agilent Technologies Inc , up 5.9% ** American Tower Corp , up 4.9% The top three S&P 500 .PL.INX percentage losers: ** Hewlett Packard Enterprise Co , down 12.1% ** Wynn Resorts Ltd , down 6% ** State Street Corp , down 5.5% The top three NYSE ... | The top three S&P 500 .PG.INX percentage gainers: ** Coty Inc , up 6.3% ** Agilent Technologies Inc , up 5.9% ** American Tower Corp , up 4.9% The top three S&P 500 .PL.INX percentage losers: ** Hewlett Packard Enterprise Co , down 12.1% ** Wynn Resorts Ltd , down 6% ** State Street Corp , down 5.5% The top three NYSE ... | The top three S&P 500 .PG.INX percentage gainers: ** Coty Inc , up 6.3% ** Agilent Technologies Inc , up 5.9% ** American Tower Corp , up 4.9% The top three S&P 500 .PL.INX percentage losers: ** Hewlett Packard Enterprise Co , down 12.1% ** Wynn Resorts Ltd , down 6% ** State Street Corp , down 5.5% The top three NYSE ... |
37462.0 | 2020-05-22 00:00:00 UTC | Uncertainty Remains Even After Aurora’s U.S. Market Debut, Says Analyst | ACB | https://www.nasdaq.com/articles/uncertainty-remains-even-after-auroras-u.s.-market-debut-says-analyst-2020-05-22 | nan | nan | Over the last five days, Aurora Cannabis (ACB) shares have blasted off to the tune of 158%. But the extent of the company’s struggles is reflected by the fact that even after these mercurial gains, shares are still down by 34% year-to-date. Nevertheless, sentiment has changed recently, which begs the question: has the ... | Over the last five days, Aurora Cannabis (ACB) shares have blasted off to the tune of 158%. The analyst consensus rates ACB a Hold based on 3 Buys, 3 Sells and 9 Holds. (See ACB price targets and analyst ratings on TipRanks) The views and opinions expressed herein are the views and opinions of the author and do not nec... | Over the last five days, Aurora Cannabis (ACB) shares have blasted off to the tune of 158%. (See ACB price targets and analyst ratings on TipRanks) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The analyst consensus rates ACB a Hold... | (See ACB price targets and analyst ratings on TipRanks) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Over the last five days, Aurora Cannabis (ACB) shares have blasted off to the tune of 158%. The analyst consensus rates ACB a Hold... | Over the last five days, Aurora Cannabis (ACB) shares have blasted off to the tune of 158%. The analyst consensus rates ACB a Hold based on 3 Buys, 3 Sells and 9 Holds. (See ACB price targets and analyst ratings on TipRanks) The views and opinions expressed herein are the views and opinions of the author and do not nec... |
37463.0 | 2020-05-22 00:00:00 UTC | Aurora Cannabis Finally Enters the U.S. -- Here's Why You Should Hold the Applause | ACB | https://www.nasdaq.com/articles/aurora-cannabis-finally-enters-the-u.s.-heres-why-you-should-hold-the-applause-2020-05-22 | nan | nan | For years, there was no hotter investment on the planet than marijuana stocks. With Canada legalizing recreational cannabis in 2018 and tens of billions of dollars in sales being conducted annually in the black market worldwide, the door appeared to be wide open for North American licensed producers to seize this oppor... | Millennials' favorite pot stock has been an eyesore Arguably the biggest disappointment of all has been Aurora Cannabis (NYSE: ACB). With Canada legalizing recreational cannabis in 2018 and tens of billions of dollars in sales being conducted annually in the black market worldwide, the door appeared to be wide open for... | Millennials' favorite pot stock has been an eyesore Arguably the biggest disappointment of all has been Aurora Cannabis (NYSE: ACB). The most popular pot stock among millennial investors was, at this time last year, projected to produce more than 650,000 kilos of marijuana annually at its peak. Despite its notable glob... | Millennials' favorite pot stock has been an eyesore Arguably the biggest disappointment of all has been Aurora Cannabis (NYSE: ACB). Despite its notable global presence, Aurora managed a meager $4 million Canadian in overseas sales during the fiscal third quarter (ended March 31, 2020) and hadn't yet outlined its strat... | Millennials' favorite pot stock has been an eyesore Arguably the biggest disappointment of all has been Aurora Cannabis (NYSE: ACB). The most popular pot stock among millennial investors was, at this time last year, projected to produce more than 650,000 kilos of marijuana annually at its peak. Following the closing be... |
37464.0 | 2020-05-22 00:00:00 UTC | BUZZ-U.S. STOCKS ON THE MOVE-Tetraphase Pharma, Aurora Cannabis, HPE | ACB | https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tetraphase-pharma-aurora-cannabis-hpe-2020-05-22 | nan | nan | Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
U.S. stock index futures retreated on Friday as growing tensions between Washington and Beijing added to fears of a slower recovery from a coronavirus-led r... | The top three NYSE percentage gainers premarket .PRPG.NQ: ** Voxeljet AG , up 15.8% ** Delek Logistics Partners LP , up 9.0% ** Noble Corporation Plc , up 8.9% The top three NYSE percentage losers premarket .PRPL.NQ: ** MaxLinear Inc , down 7.7% ** Hewlett Packard Enterprise Co , down 6.9% ** Amphenol Corp , down 6.8% ... | The top three NYSE percentage gainers premarket .PRPG.NQ: ** Voxeljet AG , up 15.8% ** Delek Logistics Partners LP , up 9.0% ** Noble Corporation Plc , up 8.9% The top three NYSE percentage losers premarket .PRPL.NQ: ** MaxLinear Inc , down 7.7% ** Hewlett Packard Enterprise Co , down 6.9% ** Amphenol Corp , down 6.8% ... | The top three NYSE percentage gainers premarket .PRPG.NQ: ** Voxeljet AG , up 15.8% ** Delek Logistics Partners LP , up 9.0% ** Noble Corporation Plc , up 8.9% The top three NYSE percentage losers premarket .PRPL.NQ: ** MaxLinear Inc , down 7.7% ** Hewlett Packard Enterprise Co , down 6.9% ** Amphenol Corp , down 6.8% ... | The top three NYSE percentage gainers premarket .PRPG.NQ: ** Voxeljet AG , up 15.8% ** Delek Logistics Partners LP , up 9.0% ** Noble Corporation Plc , up 8.9% The top three NYSE percentage losers premarket .PRPL.NQ: ** MaxLinear Inc , down 7.7% ** Hewlett Packard Enterprise Co , down 6.9% ** Amphenol Corp , down 6.8% ... |
37465.0 | 2020-05-22 00:00:00 UTC | Aurora Cannabis To Enter U.S. Market With Reliva Acquisition | ACB | https://www.nasdaq.com/articles/aurora-cannabis-to-enter-u.s.-market-with-reliva-acquisition-2020-05-22 | nan | nan | (RTTNews) - Canadian cannabis company Aurora Cannabis Inc. has announced its entry into the lucrative U.S. market with its acquisition of Massachusetts-based Reliva LLC, a seller of hemp-derived cannabidiol or CBD products.
Under the terms of the deal, Aurora will pay about $40 million of its common shares to members o... | The transaction includes a potential payment by Aurora up to an additional $45 million over the next two years upon Reliva achieving certain financial targets. Aurora noted that together with Reliva, it expects to be positioned as a meaningful player in the U.S., the world's largest cannabinoid market. Reliva's CEO, Mi... | (RTTNews) - Canadian cannabis company Aurora Cannabis Inc. has announced its entry into the lucrative U.S. market with its acquisition of Massachusetts-based Reliva LLC, a seller of hemp-derived cannabidiol or CBD products. Reliva's acquisition will provide Aurora with a retail hemp-derived CBD brand that is currently ... | (RTTNews) - Canadian cannabis company Aurora Cannabis Inc. has announced its entry into the lucrative U.S. market with its acquisition of Massachusetts-based Reliva LLC, a seller of hemp-derived cannabidiol or CBD products. The transaction will combine Aurora's Canadian recreational brands as well as its Canadian and E... | (RTTNews) - Canadian cannabis company Aurora Cannabis Inc. has announced its entry into the lucrative U.S. market with its acquisition of Massachusetts-based Reliva LLC, a seller of hemp-derived cannabidiol or CBD products. The additional payment will be in Aurora shares, cash or a combination of both. Reliva's acquisi... |
37466.0 | 2020-05-22 00:00:00 UTC | 3 Small-Cap Stocks to Trade as They Rise From the Ashes | ACB | https://www.nasdaq.com/articles/3-small-cap-stocks-to-trade-as-they-rise-from-the-ashes-2020-05-22 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
On the surface, Thursday seemed like any other session when profit-taking strikes. The S&P 500 and Nasdaq took well-deserved breathers, declining 0.61% and 1.09%, respectively. But if you look closer, you’ll see an important theme. While leaders lagged, lag... | Aurora Cannabis (NYSE:ACB) and Cronos Group (NASDAQ:CRON) joined Tilray as the market’s biggest gainers. ACB has run too far, and I find the daily 30% moves to be a little too insane for my taste. 7 Dow Jones Stocks to Buy With Fortress-Like Balance Sheets While some small-caps have yet to crawl out of the dumpster, ot... | Aurora Cannabis (NYSE:ACB) and Cronos Group (NASDAQ:CRON) joined Tilray as the market’s biggest gainers. ACB has run too far, and I find the daily 30% moves to be a little too insane for my taste. Bed Bath and Beyond (NASDAQ:BBBY) Tilray (NASDAQ:TLRY) SeaWorld Entertainment (NYSE:SEAS) Let’s take a closer look at the p... | Aurora Cannabis (NYSE:ACB) and Cronos Group (NASDAQ:CRON) joined Tilray as the market’s biggest gainers. ACB has run too far, and I find the daily 30% moves to be a little too insane for my taste. InvestorPlace - Stock Market News, Stock Advice & Trading Tips On the surface, Thursday seemed like any other session when ... | Aurora Cannabis (NYSE:ACB) and Cronos Group (NASDAQ:CRON) joined Tilray as the market’s biggest gainers. ACB has run too far, and I find the daily 30% moves to be a little too insane for my taste. Bed Bath and Beyond (NASDAQ:BBBY) Tilray (NASDAQ:TLRY) SeaWorld Entertainment (NYSE:SEAS) Let’s take a closer look at the p... |
37467.0 | 2020-05-21 00:00:00 UTC | Aurora Cannabis: Blossoming Opportunity in a Battered Industry | ACB | https://www.nasdaq.com/articles/aurora-cannabis%3A-blossoming-opportunity-in-a-battered-industry-2020-05-21 | nan | nan | The dot-com bubble almost two decades ago inflicted painful stock losses on historically bullish investors. Mega-caps like Apple saw its equity crash, only to later grow far beyond once expensive valuations. New products were in inning one of a fruitful road to ubiquity. I believe a similar opportunity is materializing... | To me, Aurora Cannabis (NYSE: ACB) is best in breed to win going forward. Inventory has swelled, but industry low growing costs equip Aurora with the ability to profitably adjust by undercutting legal and illegal competition if need be. The cannabis company renegotiated and relaxed debt covenants to add flexibility to ... | To me, Aurora Cannabis (NYSE: ACB) is best in breed to win going forward. Poised to Gain With Aurora's industry low production cost of $0.85 per gram, they have pricing flexibility with products. Inventory has swelled, but industry low growing costs equip Aurora with the ability to profitably adjust by undercutting leg... | To me, Aurora Cannabis (NYSE: ACB) is best in breed to win going forward. Aurora Cannabis has extensive product lines within cannabis 2.0 categories that are performing well early on. 10 stocks we like better than Aurora Cannabis Inc. | To me, Aurora Cannabis (NYSE: ACB) is best in breed to win going forward. Poised to Gain With Aurora's industry low production cost of $0.85 per gram, they have pricing flexibility with products. No other company produces for under $1.00 and most are well above that mark. |
37468.0 | 2020-05-21 00:00:00 UTC | TSX falls 0.75% to 14,884.85 | ACB | https://www.nasdaq.com/articles/tsx-falls-0.75-to-14884.85-2020-05-21 | nan | nan | * The Toronto Stock Exchange's TSX falls 0.75 percent to 14,884.85
* Leading the index were Lightspeed POS Inc , up 37.8%, Aurora Cannabis Inc ACB.TO, up 35.3%, and Cronos Group Inc CRON.TO, higher by 11%.
* Lagging shares were Cineplex Inc CGX.TO, down 13.9%, Ivanhoe Mines Ltd IVN.TO, down 5.4%, and First Quantum Mine... | * The Toronto Stock Exchange's TSX falls 0.75 percent to 14,884.85 * Leading the index were Lightspeed POS Inc , up 37.8%, Aurora Cannabis Inc ACB.TO, up 35.3%, and Cronos Group Inc CRON.TO, higher by 11%. * Lagging shares were Cineplex Inc CGX.TO, down 13.9%, Ivanhoe Mines Ltd IVN.TO, down 5.4%, and First Quantum Mine... | * The Toronto Stock Exchange's TSX falls 0.75 percent to 14,884.85 * Leading the index were Lightspeed POS Inc , up 37.8%, Aurora Cannabis Inc ACB.TO, up 35.3%, and Cronos Group Inc CRON.TO, higher by 11%. * On the TSX 85 issues rose and 142 fell as a 0.6-to-1 ratio favored decliners. * The most heavily traded shares b... | * The Toronto Stock Exchange's TSX falls 0.75 percent to 14,884.85 * Leading the index were Lightspeed POS Inc , up 37.8%, Aurora Cannabis Inc ACB.TO, up 35.3%, and Cronos Group Inc CRON.TO, higher by 11%. * The most heavily traded shares by volume were Sun Life Financial Inc SLF.TO, Manulife Financial Corp MFC.TO and ... | * The Toronto Stock Exchange's TSX falls 0.75 percent to 14,884.85 * Leading the index were Lightspeed POS Inc , up 37.8%, Aurora Cannabis Inc ACB.TO, up 35.3%, and Cronos Group Inc CRON.TO, higher by 11%. * The most heavily traded shares by volume were Sun Life Financial Inc SLF.TO, Manulife Financial Corp MFC.TO and ... |
37469.0 | 2020-05-21 00:00:00 UTC | Why Aurora Cannabis Stock Is Rocketing Higher Today | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-stock-is-rocketing-higher-today-2020-05-21 | nan | nan | What happened
Shares of Aurora Cannabis (NYSE: ACB) soared on Thursday after the marijuana producer said it reached an agreement to acquire a leading U.S.-based CBD brand.
As of 2:50 p.m. EDT, Aurora's stock was up more than 28%.
So what
After the market closed on Wednesday, Aurora announced that it struck a deal to ... | What happened Shares of Aurora Cannabis (NYSE: ACB) soared on Thursday after the marijuana producer said it reached an agreement to acquire a leading U.S.-based CBD brand. So what After the market closed on Wednesday, Aurora announced that it struck a deal to acquire Reliva LLC, a popular retail cannabidiol (CBD) brand... | What happened Shares of Aurora Cannabis (NYSE: ACB) soared on Thursday after the marijuana producer said it reached an agreement to acquire a leading U.S.-based CBD brand. So what After the market closed on Wednesday, Aurora announced that it struck a deal to acquire Reliva LLC, a popular retail cannabidiol (CBD) brand... | What happened Shares of Aurora Cannabis (NYSE: ACB) soared on Thursday after the marijuana producer said it reached an agreement to acquire a leading U.S.-based CBD brand. So what After the market closed on Wednesday, Aurora announced that it struck a deal to acquire Reliva LLC, a popular retail cannabidiol (CBD) brand... | What happened Shares of Aurora Cannabis (NYSE: ACB) soared on Thursday after the marijuana producer said it reached an agreement to acquire a leading U.S.-based CBD brand. 10 stocks we like better than Aurora Cannabis Inc. * David and Tom just revealed what they believe are the ten best stocks for investors to buy righ... |
37470.0 | 2020-05-21 00:00:00 UTC | BUZZ-U.S. STOCKS ON THE MOVE-L Brands, Akorn, Aurora Cannabis | ACB | https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-l-brands-akorn-aurora-cannabis-2020-05-21 | nan | nan | Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
Wall Street's main indexes eased on Thursday from more than two-month highs hit in the previous session, as growing Sino-U.S. tensions and concerns about a ... | The top three S&P 500 .PG.INX percentage gainers: ** L Brands Inc , up 16.7% ** Gap Inc , up 10.5% ** Norwgn Crus Line , up 9.2% The top three S&P 500 .PL.INX percentage losers: ** Norwegian Cruise Line Holdings Ltd , down 7.3% ** Boston Scientific Corp , down 6.5% ** Hormel Foods Corp , down 4.5% The top three NYSE .P... | The top three S&P 500 .PG.INX percentage gainers: ** L Brands Inc , up 16.7% ** Gap Inc , up 10.5% ** Norwgn Crus Line , up 9.2% The top three S&P 500 .PL.INX percentage losers: ** Norwegian Cruise Line Holdings Ltd , down 7.3% ** Boston Scientific Corp , down 6.5% ** Hormel Foods Corp , down 4.5% The top three NYSE .P... | The top three S&P 500 .PG.INX percentage gainers: ** L Brands Inc , up 16.7% ** Gap Inc , up 10.5% ** Norwgn Crus Line , up 9.2% The top three S&P 500 .PL.INX percentage losers: ** Norwegian Cruise Line Holdings Ltd , down 7.3% ** Boston Scientific Corp , down 6.5% ** Hormel Foods Corp , down 4.5% The top three NYSE .P... | The top three S&P 500 .PG.INX percentage gainers: ** L Brands Inc , up 16.7% ** Gap Inc , up 10.5% ** Norwgn Crus Line , up 9.2% The top three S&P 500 .PL.INX percentage losers: ** Norwegian Cruise Line Holdings Ltd , down 7.3% ** Boston Scientific Corp , down 6.5% ** Hormel Foods Corp , down 4.5% The top three NYSE .P... |
37471.0 | 2020-05-21 00:00:00 UTC | Stock Market News: Aurora Shares Smoke Higher on U.S. CBD Buy; United Airlines Keeps Climbing | ACB | https://www.nasdaq.com/articles/stock-market-news%3A-aurora-shares-smoke-higher-on-u.s.-cbd-buy-united-airlines-keeps | nan | nan | Thursday morning brought mixed moves from investors on Wall Street as they tried to digest countervailing views of the economy.
Jobless claims came in at 4.4 million when you add up both state and coronavirus-related federal assistance, and there's still a lot of concern about how quickly the tens of millions of newly ... | Aurora Cannabis (NYSE: ACB) has been in the news a lot lately, and it made a strategic move that caused its stock to soar Thursday. The purchase of the Massachusetts-based CBD company should immediately boost Aurora's adjusted pre-tax operating earnings, thanks to Reliva's positive EBITDA over the past 12 months. The a... | Aurora Cannabis (NYSE: ACB) has been in the news a lot lately, and it made a strategic move that caused its stock to soar Thursday. Meanwhile, United Airlines Holdings (NASDAQ: UAL) continued to gain altitude as carriers aim to find a pathway toward getting passengers back into the skies. Aurora heads south of the bord... | Aurora Cannabis (NYSE: ACB) has been in the news a lot lately, and it made a strategic move that caused its stock to soar Thursday. Aurora heads south of the border Shares of Aurora Cannabis jumped 26% on Thursday morning. The Canadian cannabis company has struggled lately, but investors are excited about something tha... | Aurora Cannabis (NYSE: ACB) has been in the news a lot lately, and it made a strategic move that caused its stock to soar Thursday. Meanwhile, United Airlines Holdings (NASDAQ: UAL) continued to gain altitude as carriers aim to find a pathway toward getting passengers back into the skies. The Canadian cannabis company ... |
37472.0 | 2020-05-21 00:00:00 UTC | Stock Alert: Aurora Cannabis Climbs 27% As It Enters US Cannabidiol Market | ACB | https://www.nasdaq.com/articles/stock-alert%3A-aurora-cannabis-climbs-27-as-it-enters-us-cannabidiol-market-2020-05-21 | nan | nan | (RTTNews) - Shares of Aurora Cannabis Inc. (ACB) are surging more than 27% Thursday morning after the company announced its decision to acquire U.S. based hemp-derived CBD retailer, Reliva. The acquisition will enable the company to enter the U.S. cannabidiol (CBD) market.
Wednesday the marijuana producer said, it has ... | (RTTNews) - Shares of Aurora Cannabis Inc. (ACB) are surging more than 27% Thursday morning after the company announced its decision to acquire U.S. based hemp-derived CBD retailer, Reliva. As per the deal, members of Reliva will receive Aurora common shares worth approximately $40 million. The transaction also include... | (RTTNews) - Shares of Aurora Cannabis Inc. (ACB) are surging more than 27% Thursday morning after the company announced its decision to acquire U.S. based hemp-derived CBD retailer, Reliva. The acquisition will enable the company to enter the U.S. cannabidiol (CBD) market. As per the deal, members of Reliva will receiv... | (RTTNews) - Shares of Aurora Cannabis Inc. (ACB) are surging more than 27% Thursday morning after the company announced its decision to acquire U.S. based hemp-derived CBD retailer, Reliva. As per the deal, members of Reliva will receive Aurora common shares worth approximately $40 million. The transaction also include... | (RTTNews) - Shares of Aurora Cannabis Inc. (ACB) are surging more than 27% Thursday morning after the company announced its decision to acquire U.S. based hemp-derived CBD retailer, Reliva. The acquisition will enable the company to enter the U.S. cannabidiol (CBD) market. Wednesday the marijuana producer said, it has ... |
37473.0 | 2020-05-21 00:00:00 UTC | TSX edges lower on dismal monthly jobs data | ACB | https://www.nasdaq.com/articles/tsx-edges-lower-on-dismal-monthly-jobs-data-2020-05-21 | nan | nan | May 21 (Reuters) - Canada's main stock index edged lower on Thursday, weighed by bleak monthly domestic jobs data and escalating tensions between the United States and China.
The nation lost 226,700 jobs in April, ADP payroll data showed, as the lockdowns imposed to the curb the spread of the coronavirus impacted econo... | * The largest percentage gainers on the TSX was Aurora Cannabis Inc ACB.TO, which jumped 27.3% after the pot company agreed to buy U.S.-based Reliva LLC for $40 million in an all-stock deal. May 21 (Reuters) - Canada's main stock index edged lower on Thursday, weighed by bleak monthly domestic jobs data and escalating ... | * The largest percentage gainers on the TSX was Aurora Cannabis Inc ACB.TO, which jumped 27.3% after the pot company agreed to buy U.S.-based Reliva LLC for $40 million in an all-stock deal. The industrials sector .GSPTTIN fell 0.3%. GOL/ * On the TSX, 77 issues were higher, while 140 issues declined for a 1.82-to-1 ra... | * The largest percentage gainers on the TSX was Aurora Cannabis Inc ACB.TO, which jumped 27.3% after the pot company agreed to buy U.S.-based Reliva LLC for $40 million in an all-stock deal. May 21 (Reuters) - Canada's main stock index edged lower on Thursday, weighed by bleak monthly domestic jobs data and escalating ... | * The largest percentage gainers on the TSX was Aurora Cannabis Inc ACB.TO, which jumped 27.3% after the pot company agreed to buy U.S.-based Reliva LLC for $40 million in an all-stock deal. May 21 (Reuters) - Canada's main stock index edged lower on Thursday, weighed by bleak monthly domestic jobs data and escalating ... |
37474.0 | 2020-05-21 00:00:00 UTC | Tilray Stock Is a Loser in the Cannabis World | ACB | https://www.nasdaq.com/articles/tilray-stock-is-a-loser-in-the-cannabis-world-2020-05-21 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Cannabis stocks have found a bottom, and Tilray (NASDAQ:TLRY) is no exception. TLRY stock has more than tripled off its March lows.
Source: Jarretera / Shutterstock.com
Of course, those lows came amid a market stampede out of cannabis stocks. And despite th... | What’s interesting about the broad strokes of the release is that it sounds awfully similar to that of Aurora Cannabis (NYSE:ACB), who reported earnings three days later. Yet ACB stock nearly tripled in three sessions into and out of earnings. After all, any investor who owns TLRY stock or ACB stock has to believe in t... | What’s interesting about the broad strokes of the release is that it sounds awfully similar to that of Aurora Cannabis (NYSE:ACB), who reported earnings three days later. Yet ACB stock nearly tripled in three sessions into and out of earnings. After all, any investor who owns TLRY stock or ACB stock has to believe in t... | After all, any investor who owns TLRY stock or ACB stock has to believe in the long-term opportunity in cannabis. What’s interesting about the broad strokes of the release is that it sounds awfully similar to that of Aurora Cannabis (NYSE:ACB), who reported earnings three days later. Yet ACB stock nearly tripled in thr... | What’s interesting about the broad strokes of the release is that it sounds awfully similar to that of Aurora Cannabis (NYSE:ACB), who reported earnings three days later. Yet ACB stock nearly tripled in three sessions into and out of earnings. After all, any investor who owns TLRY stock or ACB stock has to believe in t... |
37475.0 | 2020-05-21 00:00:00 UTC | BUZZ-U.S. STOCKS ON THE MOVE-Akorn, scPharmaceuticals, Teekay Tankers | ACB | https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-akorn-scpharmaceuticals-teekay-tankers-2020-05-21 | nan | nan | Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
U.S. stock indexes eyed a weaker open on Thursday as growing Sino-U.S. tensions and weak retail earnings added to worries about the pace of a recovery from ... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock indexes eyed a weaker open on Thursday as growing Sino-U.S. tensions and weak retail earnings added to worries about the pace of a recovery from ... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock indexes eyed a weaker open on Thursday as growing Sino-U.S. tensions and weak retail earnings added to worries about the pace of a recovery from ... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock indexes eyed a weaker open on Thursday as growing Sino-U.S. tensions and weak retail earnings added to worries about the pace of a recovery from ... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock indexes eyed a weaker open on Thursday as growing Sino-U.S. tensions and weak retail earnings added to worries about the pace of a recovery from ... |
37476.0 | 2020-05-21 00:00:00 UTC | Aurora Cannabis Strikes a Deal to Enter the U.S. CBD Market | ACB | https://www.nasdaq.com/articles/aurora-cannabis-strikes-a-deal-to-enter-the-u.s.-cbd-market-2020-05-21 | nan | nan | Aurora Cannabis (NYSE: ACB) is making a long-awaited move into the largest legal cannabis market in the world. The marijuana producer announced on Wednesday that it has entered into an agreement to acquire Reliva, one of the best-selling retail cannabidiol (CBD) brands in the U.S.
Cannabidiol is one of the many compou... | Aurora Cannabis (NYSE: ACB) is making a long-awaited move into the largest legal cannabis market in the world. In turn, retail CBD sales could grow to as much as $24 billion by 2025 in the U.S. alone, according to the Brightfield Group, a cannabis market researcher. In this way, the earn-out is intended to reduce risk ... | Aurora Cannabis (NYSE: ACB) is making a long-awaited move into the largest legal cannabis market in the world. Aurora Cannabis is claiming its share of the U.S.CBD market by acquiring Reliva. Mo' CBD, mo' profits Aurora says the acquisition will be immediately accretive on an adjusted EBITDA basis, which would help it ... | Aurora Cannabis (NYSE: ACB) is making a long-awaited move into the largest legal cannabis market in the world. The marijuana producer announced on Wednesday that it has entered into an agreement to acquire Reliva, one of the best-selling retail cannabidiol (CBD) brands in the U.S. Cannabidiol is one of the many compoun... | Aurora Cannabis (NYSE: ACB) is making a long-awaited move into the largest legal cannabis market in the world. "We have taken the time necessary to carefully assess the company's entry into the U.S. market and we firmly believe that the combination with Reliva will create significant long-term value, as Reliva provides... |
37477.0 | 2020-05-21 00:00:00 UTC | Here's How Canada Blew Its Chance to Be a Cannabis Leader | ACB | https://www.nasdaq.com/articles/heres-how-canada-blew-its-chance-to-be-a-cannabis-leader-2020-05-21 | nan | nan | For years, cannabis stocks were virtually unstoppable. Following a more-than-tripling in worldwide sales between 2014 and 2018 to $10.9 billion, Wall Street and investors sent pot stock valuations into the stratosphere.
At the center of this growth trend was Canada. Even though the U.S. offered far more potential in do... | Even though it remains the most popular pot stock, Aurora Cannabis (NYSE: ACB) is the perfect example of a company that didn't pay any heed to the risks involved with operating in the marijuana industry. Canopy Growth (NYSE: CGC), Aurora's biggest production rival, announced that it would be permanently closing its Ald... | Even though it remains the most popular pot stock, Aurora Cannabis (NYSE: ACB) is the perfect example of a company that didn't pay any heed to the risks involved with operating in the marijuana industry. Canadian licensed producers were far too overzealous The other major issue here is that Canadian licensed producers ... | Even though it remains the most popular pot stock, Aurora Cannabis (NYSE: ACB) is the perfect example of a company that didn't pay any heed to the risks involved with operating in the marijuana industry. Regulations stifled Canada's cannabis rollout Obviously, the passage of the Cannabis Act in 2018 meant that there wo... | Even though it remains the most popular pot stock, Aurora Cannabis (NYSE: ACB) is the perfect example of a company that didn't pay any heed to the risks involved with operating in the marijuana industry. But it's not just Health Canada that completely bungled the rollout of recreational weed and derivatives. Canadian l... |
37478.0 | 2020-05-20 00:00:00 UTC | Why Aurora Cannabis Stock Is Falling Today | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-stock-is-falling-today-2020-05-20 | nan | nan | What happened
Shares of Aurora Cannabis (NYSE: ACB) sank on Wednesday after analysts raised concerns that the popular marijuana stock's price gains may have come too far, too fast.
As of 3 p.m. EDT, Aurora's stock was down more than 12%.
So what
Aurora's shares surged as much as 180% following the cannabis producer's... | What happened Shares of Aurora Cannabis (NYSE: ACB) sank on Wednesday after analysts raised concerns that the popular marijuana stock's price gains may have come too far, too fast. On Wednesday, Raymond James analysts Rahul Sarugaser and Michael Freeman noted that Aurora's recent gains were far larger than those of fel... | What happened Shares of Aurora Cannabis (NYSE: ACB) sank on Wednesday after analysts raised concerns that the popular marijuana stock's price gains may have come too far, too fast. On Wednesday, Raymond James analysts Rahul Sarugaser and Michael Freeman noted that Aurora's recent gains were far larger than those of fel... | What happened Shares of Aurora Cannabis (NYSE: ACB) sank on Wednesday after analysts raised concerns that the popular marijuana stock's price gains may have come too far, too fast. On Wednesday, Raymond James analysts Rahul Sarugaser and Michael Freeman noted that Aurora's recent gains were far larger than those of fel... | What happened Shares of Aurora Cannabis (NYSE: ACB) sank on Wednesday after analysts raised concerns that the popular marijuana stock's price gains may have come too far, too fast. On Wednesday, Raymond James analysts Rahul Sarugaser and Michael Freeman noted that Aurora's recent gains were far larger than those of fel... |
37479.0 | 2020-05-20 00:00:00 UTC | Why the Coronavirus Is a Double-Edged Sword for Aurora Cannabis | ACB | https://www.nasdaq.com/articles/why-the-coronavirus-is-a-double-edged-sword-for-aurora-cannabis-2020-05-20 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Because of the near-universal reach of the novel coronavirus, very few investment sectors have gone unscathed. Among the hardest hit is the cannabis sector, which in many ways is a double whammy. Many have given up on the green market because of its seeming... | But assuming that ACB can survive the coming game of musical chairs, the coronavirus has inadvertently offered up a catalyst: a viable platform for addressing mental health issues. Many have given up on the green market because of its seemingly unsustainable trajectory, particularly for previously growth-intensive name... | Many have given up on the green market because of its seemingly unsustainable trajectory, particularly for previously growth-intensive names like Aurora Cannabis (NYSE:ACB). Given ACB’s relatively strong international presence, this is a long-term positive for Aurora stock. Source: Shutterstock Throughout most of this ... | Many have given up on the green market because of its seemingly unsustainable trajectory, particularly for previously growth-intensive names like Aurora Cannabis (NYSE:ACB). Given ACB’s relatively strong international presence, this is a long-term positive for Aurora stock. Source: Shutterstock Throughout most of this ... | Given ACB’s relatively strong international presence, this is a long-term positive for Aurora stock. Many have given up on the green market because of its seemingly unsustainable trajectory, particularly for previously growth-intensive names like Aurora Cannabis (NYSE:ACB). Source: Shutterstock Throughout most of this ... |
37480.0 | 2020-05-20 00:00:00 UTC | BUZZ-U.S. STOCKS ON THE MOVE-Atossa, Kornit Digital, Xcel Brands | ACB | https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-atossa-kornit-digital-xcel-brands-2020-05-20 | nan | nan | Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
Wall Street's main indexes surged and the Nasdaq hit a three-month high on Wednesday, as investors clung to hopes of a recovery from a coronavirus-fueled sl... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes surged and the Nasdaq hit a three-month high on Wednesday, as investors clung to hopes of a recovery from a coronavirus-fueled sl... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes surged and the Nasdaq hit a three-month high on Wednesday, as investors clung to hopes of a recovery from a coronavirus-fueled sl... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes surged and the Nasdaq hit a three-month high on Wednesday, as investors clung to hopes of a recovery from a coronavirus-fueled sl... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh Wall Street's main indexes surged and the Nasdaq hit a three-month high on Wednesday, as investors clung to hopes of a recovery from a coronavirus-fueled sl... |
37481.0 | 2020-05-20 00:00:00 UTC | TSX rises 0.75% to 14,997.63 | ACB | https://www.nasdaq.com/articles/tsx-rises-0.75-to-14997.63-2020-05-20 | nan | nan | * The Toronto Stock Exchange's TSX rises 0.75 percent to 14,997.63
* Leading the index were Frontera Energy Corp , up 22.4%, Whitecap Resources Inc WCP.TO, up 16.5%, and Shawcor Ltd SCL.TO, higher by 15%.
* Lagging shares were Aurora Cannabis Inc ACB.TO, down 12.7%, Hexo Corp HEXO.TO, down 8.2%, and Cineplex Inc CGX.TO... | * Lagging shares were Aurora Cannabis Inc ACB.TO, down 12.7%, Hexo Corp HEXO.TO, down 8.2%, and Cineplex Inc CGX.TO, lower by 4.3%. * The Toronto Stock Exchange's TSX rises 0.75 percent to 14,997.63 * Leading the index were Frontera Energy Corp , up 22.4%, Whitecap Resources Inc WCP.TO, up 16.5%, and Shawcor Ltd SCL.TO... | * Lagging shares were Aurora Cannabis Inc ACB.TO, down 12.7%, Hexo Corp HEXO.TO, down 8.2%, and Cineplex Inc CGX.TO, lower by 4.3%. * The Toronto Stock Exchange's TSX rises 0.75 percent to 14,997.63 * Leading the index were Frontera Energy Corp , up 22.4%, Whitecap Resources Inc WCP.TO, up 16.5%, and Shawcor Ltd SCL.TO... | * Lagging shares were Aurora Cannabis Inc ACB.TO, down 12.7%, Hexo Corp HEXO.TO, down 8.2%, and Cineplex Inc CGX.TO, lower by 4.3%. * The Toronto Stock Exchange's TSX rises 0.75 percent to 14,997.63 * Leading the index were Frontera Energy Corp , up 22.4%, Whitecap Resources Inc WCP.TO, up 16.5%, and Shawcor Ltd SCL.TO... | * Lagging shares were Aurora Cannabis Inc ACB.TO, down 12.7%, Hexo Corp HEXO.TO, down 8.2%, and Cineplex Inc CGX.TO, lower by 4.3%. * The Toronto Stock Exchange's TSX rises 0.75 percent to 14,997.63 * Leading the index were Frontera Energy Corp , up 22.4%, Whitecap Resources Inc WCP.TO, up 16.5%, and Shawcor Ltd SCL.TO... |
37482.0 | 2020-05-20 00:00:00 UTC | TSX gains as higher oil prices boost energy stocks | ACB | https://www.nasdaq.com/articles/tsx-gains-as-higher-oil-prices-boost-energy-stocks-2020-05-20 | nan | nan | May 20 (Reuters) - Canada's main stock index rose on Wednesday, lifted by energy stocks as oil prices gained on signs of improving demand due to countries easing lockdown restrictions worldwide and a fall in U.S. crude inventories.
U.S. crude stockpile fell by 4.8 million barrels to 521.3 million barrels in the week to... | May 20 (Reuters) - Canada's main stock index rose on Wednesday, lifted by energy stocks as oil prices gained on signs of improving demand due to countries easing lockdown restrictions worldwide and a fall in U.S. crude inventories. * The largest percentage gainer on the TSX was aircraft repair and overhaul services pro... | May 20 (Reuters) - Canada's main stock index rose on Wednesday, lifted by energy stocks as oil prices gained on signs of improving demand due to countries easing lockdown restrictions worldwide and a fall in U.S. crude inventories. U.S. crude stockpile fell by 4.8 million barrels to 521.3 million barrels in the week to... | May 20 (Reuters) - Canada's main stock index rose on Wednesday, lifted by energy stocks as oil prices gained on signs of improving demand due to countries easing lockdown restrictions worldwide and a fall in U.S. crude inventories. * The energy sector .SPTTEN climbed 3.0% as U.S. crude CLc1 prices rose 2.6% a barrel, w... | May 20 (Reuters) - Canada's main stock index rose on Wednesday, lifted by energy stocks as oil prices gained on signs of improving demand due to countries easing lockdown restrictions worldwide and a fall in U.S. crude inventories. * The energy sector .SPTTEN climbed 3.0% as U.S. crude CLc1 prices rose 2.6% a barrel, w... |
37483.0 | 2020-05-20 00:00:00 UTC | Aurora Cannabis: More Than Half of Its Total Assets May Be Written Down | ACB | https://www.nasdaq.com/articles/aurora-cannabis%3A-more-than-half-of-its-total-assets-may-be-written-down-2020-05-20 | nan | nan | What a difference an earnings report makes if you're a shareholder of the most popular pot stock on the planet, Aurora Cannabis (NYSE: ACB).
Following a precipitous 14-month downtrend that saw Aurora's stock lose as much as 95% of its value and undergo a 1-for-12 reverse stock split in order to avoid being delisted fro... | What a difference an earnings report makes if you're a shareholder of the most popular pot stock on the planet, Aurora Cannabis (NYSE: ACB). Aurora didn't sell any low-margin wholesale or bulk cannabis, but saw adult-use weed sales climb 24%, which is likely the result of excitement surrounding the launch of higher-mar... | What a difference an earnings report makes if you're a shareholder of the most popular pot stock on the planet, Aurora Cannabis (NYSE: ACB). In the recently ended third quarter, Aurora's total assets tallied CA$4.72 billion, down from CA$5.5 billion when it ended its fiscal 2019 on June 30, 2019. Currently, 51% of the ... | What a difference an earnings report makes if you're a shareholder of the most popular pot stock on the planet, Aurora Cannabis (NYSE: ACB). In the recently ended third quarter, Aurora's total assets tallied CA$4.72 billion, down from CA$5.5 billion when it ended its fiscal 2019 on June 30, 2019. Aurora ended the most ... | What a difference an earnings report makes if you're a shareholder of the most popular pot stock on the planet, Aurora Cannabis (NYSE: ACB). Short-sellers make money when a stock declines in value. With Aurora's cash balance also likely to decline as the company continues to lose money on an operating basis, I'd conten... |
37484.0 | 2020-05-20 00:00:00 UTC | Stock Market News: Why Luckin Coffee and Aurora Cannabis Plunged Wednesday Morning | ACB | https://www.nasdaq.com/articles/stock-market-news%3A-why-luckin-coffee-and-aurora-cannabis-plunged-wednesday-morning-2020-05 | nan | nan | The stock market got its mojo back on Wednesday morning, with investors growing more excited about the future. Some market participants believe that reopening businesses will bring a strong recovery without further assistance, while others expect lawmakers in Washington to add further economic stimulus measures to supp... | Meanwhile, in the marijuana stock sector, Aurora Cannabis (NYSE: ACB) gave back some of its recent gains on fears that its rebound could prove short-lived. Some market participants believe that reopening businesses will bring a strong recovery without further assistance, while others expect lawmakers in Washington to a... | Meanwhile, in the marijuana stock sector, Aurora Cannabis (NYSE: ACB) gave back some of its recent gains on fears that its rebound could prove short-lived. The stock market got its mojo back on Wednesday morning, with investors growing more excited about the future. Luck runs out for Luckin Shares of Luckin Coffee plun... | Meanwhile, in the marijuana stock sector, Aurora Cannabis (NYSE: ACB) gave back some of its recent gains on fears that its rebound could prove short-lived. Luckin Coffee (NASDAQ: LK) saw its shares trade for the first time in more than a month, and a rush of selling pressure showed the challenges that the Chinese coffe... | Meanwhile, in the marijuana stock sector, Aurora Cannabis (NYSE: ACB) gave back some of its recent gains on fears that its rebound could prove short-lived. Following extensive bad news, investors got their first chance to trade the stock since Nasdaq suspended trading in early April -- but they might not have much time... |
37485.0 | 2020-05-20 00:00:00 UTC | This New Business Transformation Plan Makes Aurora Stock Interesting | ACB | https://www.nasdaq.com/articles/this-new-business-transformation-plan-makes-aurora-stock-interesting-2020-05-20 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
As Aurora Cannabis (NYSE:ACB) reported third-quarter results for 2020, the company’s stock surged by 69% to $11.20. Improved results coupled with a business transformation plan triggered the rally for Aurora stock.
It might not make sense to consider fresh ... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips As Aurora Cannabis (NYSE:ACB) reported third-quarter results for 2020, the company’s stock surged by 69% to $11.20. My Concluding Views on ACB Stock I believe that survival and slow growth is the right way forward for all cannabis companies. 7 Financial Sto... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips As Aurora Cannabis (NYSE:ACB) reported third-quarter results for 2020, the company’s stock surged by 69% to $11.20. My Concluding Views on ACB Stock I believe that survival and slow growth is the right way forward for all cannabis companies. This makes sens... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips As Aurora Cannabis (NYSE:ACB) reported third-quarter results for 2020, the company’s stock surged by 69% to $11.20. My Concluding Views on ACB Stock I believe that survival and slow growth is the right way forward for all cannabis companies. Cannabis 2.0 Pr... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips As Aurora Cannabis (NYSE:ACB) reported third-quarter results for 2020, the company’s stock surged by 69% to $11.20. My Concluding Views on ACB Stock I believe that survival and slow growth is the right way forward for all cannabis companies. This makes sens... |
37486.0 | 2020-05-19 00:00:00 UTC | BUZZ-U.S. STOCKS ON THE MOVE-Xenetic Biosciences, Dycom, Dynavax Technologies | ACB | https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-xenetic-biosciences-dycom-dynavax-technologies-2020-05-19 | nan | nan | Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
The S&P 500 was largely unchanged on Tuesday, after a strong rally in the prior session, as investors sifted through a mixed batch of results from major ret... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh The S&P 500 was largely unchanged on Tuesday, after a strong rally in the prior session, as investors sifted through a mixed batch of results from major ret... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh The S&P 500 was largely unchanged on Tuesday, after a strong rally in the prior session, as investors sifted through a mixed batch of results from major ret... | The top three S&P 500 .PG.INX percentage gainers: ** Advance Auto Parts Inc , up 6.1% ** HP Inc , up 5% ** Lennar Corp , up 4.9% The top three S&P 500 .PL.INX percentage losers: ** Kohl's Corp , down 7.9% ** TechnipFMC Plc , down 6.7% ** Noble Energy Inc , down 6.5% The top three NYSE .PG.N percentage gainers: ** Dycom... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh The S&P 500 was largely unchanged on Tuesday, after a strong rally in the prior session, as investors sifted through a mixed batch of results from major ret... |
37487.0 | 2020-05-19 00:00:00 UTC | Is Aurora Cannabis Stock a Buy? | ACB | https://www.nasdaq.com/articles/is-aurora-cannabis-stock-a-buy-2020-05-19 | nan | nan | Even after soaring by more than 125% over the past week, shares of Aurora Cannabis (NYSE: ACB) still have plenty of upside.
So says investment bank Ladenburg Thalmann, which reiterated its buy rating on Aurora's stock on Monday. Even after cutting his price target in half, analyst Glenn Mattson says Aurora's shares are... | Even after soaring by more than 125% over the past week, shares of Aurora Cannabis (NYSE: ACB) still have plenty of upside. "We think ACB can become a solid cash flow generator simply from the Canadian operations and, with a strong market position in Canada, the company can create significant value from here based on t... | Even after soaring by more than 125% over the past week, shares of Aurora Cannabis (NYSE: ACB) still have plenty of upside. "We think ACB can become a solid cash flow generator simply from the Canadian operations and, with a strong market position in Canada, the company can create significant value from here based on t... | Even after soaring by more than 125% over the past week, shares of Aurora Cannabis (NYSE: ACB) still have plenty of upside. "We think ACB can become a solid cash flow generator simply from the Canadian operations and, with a strong market position in Canada, the company can create significant value from here based on t... | "We think ACB can become a solid cash flow generator simply from the Canadian operations and, with a strong market position in Canada, the company can create significant value from here based on this one market," Mattson said. Even after soaring by more than 125% over the past week, shares of Aurora Cannabis (NYSE: ACB... |
37488.0 | 2020-05-19 00:00:00 UTC | TSX lifted by energy stocks, COVID-19 vaccine hopes | ACB | https://www.nasdaq.com/articles/tsx-lifted-by-energy-stocks-covid-19-vaccine-hopes-2020-05-19 | nan | nan | May 19 (Reuters) - Canada's main stock index hit a one-week high on Tuesday after an extended weekend, as rising oil prices lifted the energy sector, while positive results from an early stage trial of a COVID-19 vaccine added to optimism.
* A gradual reopening of select retailers and auto dealerships in Ontario after ... | May 19 (Reuters) - Canada's main stock index hit a one-week high on Tuesday after an extended weekend, as rising oil prices lifted the energy sector, while positive results from an early stage trial of a COVID-19 vaccine added to optimism. * A gradual reopening of select retailers and auto dealerships in Ontario after ... | * The energy sector .SPTTEN climbed 6.3% as U.S. crude CLc1 prices were up 4.2% a barrel, while Brent crude LCOc1 added 0.6%. * On the TSX, 199 issues gained, while 29 issues declined for a 6.86-to-1 ratio favoring gainers, with 43.22 million shares traded. * The largest percentage gainer on the TSX was Aurora Cannabis... | May 19 (Reuters) - Canada's main stock index hit a one-week high on Tuesday after an extended weekend, as rising oil prices lifted the energy sector, while positive results from an early stage trial of a COVID-19 vaccine added to optimism. * On the TSX, 199 issues gained, while 29 issues declined for a 6.86-to-1 ratio ... | May 19 (Reuters) - Canada's main stock index hit a one-week high on Tuesday after an extended weekend, as rising oil prices lifted the energy sector, while positive results from an early stage trial of a COVID-19 vaccine added to optimism. * On the TSX, 199 issues gained, while 29 issues declined for a 6.86-to-1 ratio ... |
37489.0 | 2020-05-19 00:00:00 UTC | Did You Give Up Too Soon on Marijuana Stocks? | ACB | https://www.nasdaq.com/articles/did-you-give-up-too-soon-on-marijuana-stocks-2020-05-19 | nan | nan | The COVID-19 pandemic has wreaked havoc on the global economy. For most businesses, the struggle is continuing, while a few -- like those in the healthcare sector -- are comparatively secure, with the companies within working to fight the crisis. Healthcare might be a predictable safe space amid the pandemic, but there... | Meanwhile, Aurora Cannabis's (NYSE: ACB) third-quarter results were a tremendous surprise. As CIBC analyst John Zamporo noted, "The catalyst for the Canadian cannabis market in 2020 was obvious: a wave of stores in Ontario -- and, to some extent, Quebec and British Columbia -- was set to propel the industry. I like Cro... | Meanwhile, Aurora Cannabis's (NYSE: ACB) third-quarter results were a tremendous surprise. These were among the many factors that affected Canadian cannabis companies' performance last year. The pandemic made CIBC Capital Markets (an investment banking subsidiary of the Canadian Imperial Bank of Commerce, or CIBC) slas... | Meanwhile, Aurora Cannabis's (NYSE: ACB) third-quarter results were a tremendous surprise. In the U.S., medical marijuana is legal in 33 states and the District of Columbia, while recreational use is legal in 11 states and D.C. As legalization progressed, investors showed interest in emerging Canadian and U.S. cannabis... | Meanwhile, Aurora Cannabis's (NYSE: ACB) third-quarter results were a tremendous surprise. If not for the pandemic, more legal stores could have opened this year in Ontario -- a key factor affecting Canadian sales. With rising cannabis sales, most cannabis companies recorded good first-quarter results. |
37490.0 | 2020-05-19 00:00:00 UTC | TSX futures jump on virus vaccine optimism | ACB | https://www.nasdaq.com/articles/tsx-futures-jump-on-virus-vaccine-optimism-2020-05-19 | nan | nan | May 19 (Reuters) - Canada's main stock index futures rose 2% on Tuesday, after a long holiday weekend, as sentiment was lifted by positive data from an early-stage study testing a coronavirus vaccine.
Wall Street rallied on Monday after drugmaker Moderna Inc's MRNA.O experimental COVID-19 vaccine appeared safe and show... | Aurora Cannabis Inc ACB.TO: Canaccord Genuity cuts target price to C$24 from C$27 Chorus Aviation Inc CHR.TO: RBC cuts target price to C$4.50 from C$6 Equinox Gold Corp EQX.TO: National Bank of Canada raises target price to C$18.50 from C$17.50 Onex Corp ONEX.TO: Canaccord Genuity raises price target to C$75 from C$72 ... | Aurora Cannabis Inc ACB.TO: Canaccord Genuity cuts target price to C$24 from C$27 Chorus Aviation Inc CHR.TO: RBC cuts target price to C$4.50 from C$6 Equinox Gold Corp EQX.TO: National Bank of Canada raises target price to C$18.50 from C$17.50 Onex Corp ONEX.TO: Canaccord Genuity raises price target to C$75 from C$72 ... | Aurora Cannabis Inc ACB.TO: Canaccord Genuity cuts target price to C$24 from C$27 Chorus Aviation Inc CHR.TO: RBC cuts target price to C$4.50 from C$6 Equinox Gold Corp EQX.TO: National Bank of Canada raises target price to C$18.50 from C$17.50 Onex Corp ONEX.TO: Canaccord Genuity raises price target to C$75 from C$72 ... | Aurora Cannabis Inc ACB.TO: Canaccord Genuity cuts target price to C$24 from C$27 Chorus Aviation Inc CHR.TO: RBC cuts target price to C$4.50 from C$6 Equinox Gold Corp EQX.TO: National Bank of Canada raises target price to C$18.50 from C$17.50 Onex Corp ONEX.TO: Canaccord Genuity raises price target to C$75 from C$72 ... |
37491.0 | 2020-05-19 00:00:00 UTC | Why Aurora Cannabis' Big Bounce Might Not Last Very Long | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-big-bounce-might-not-last-very-long-2020-05-19 | nan | nan | It's been quite a while since anyone could point to Aurora Cannabis (NYSE: ACB) as a hot pot stock. But that's an apt description for the Canadian cannabis producer after it announced surprisingly positive fiscal 2020 third-quarter results last Thursday. Aurora's share price has skyrocketed more than 160% since its Q3 ... | It's been quite a while since anyone could point to Aurora Cannabis (NYSE: ACB) as a hot pot stock. Although investors were mainly focused on Aurora's revenue beat in Q3, the company continued to lose a lot of money -- 137.4 million in Canadian dollars to be exact. CFO Glenn Ibbott said in Aurora's Q3 conference call t... | It's been quite a while since anyone could point to Aurora Cannabis (NYSE: ACB) as a hot pot stock. But that's an apt description for the Canadian cannabis producer after it announced surprisingly positive fiscal 2020 third-quarter results last Thursday. A short rebound It isn't uncommon that shares jump after a compan... | It's been quite a while since anyone could point to Aurora Cannabis (NYSE: ACB) as a hot pot stock. A short rebound It isn't uncommon that shares jump after a company beats analysts' revenue estimates as Aurora did. The cannabis producer's solid revenue beat almost certainly led to some short-sellers buying the stock t... | It's been quite a while since anyone could point to Aurora Cannabis (NYSE: ACB) as a hot pot stock. Like Aurora Cannabis has. What about the prospects of a partner stepping in to provide cash? |
37492.0 | 2020-05-19 00:00:00 UTC | BUZZ-U.S. STOCKS ON THE MOVE-Dynavax Technologies, Home Depot, PBF Energy | ACB | https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-dynavax-technologies-home-depot-pbf-energy-2020-05-19 | nan | nan | Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
U.S. stock index futures eased on Tuesday, handing back gains from the S&P 500's best day in six weeks in the previous session, as disappointing results fro... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock index futures eased on Tuesday, handing back gains from the S&P 500's best day in six weeks in the previous session, as disappointing results fro... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock index futures eased on Tuesday, handing back gains from the S&P 500's best day in six weeks in the previous session, as disappointing results fro... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock index futures eased on Tuesday, handing back gains from the S&P 500's best day in six weeks in the previous session, as disappointing results fro... | Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh U.S. stock index futures eased on Tuesday, handing back gains from the S&P 500's best day in six weeks in the previous session, as disappointing results fro... |
37493.0 | 2020-05-19 00:00:00 UTC | Why Aurora Cannabis Stock Tanked Today | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-stock-tanked-today-2020-05-19 | nan | nan | What happened
Aurora Cannabis' (NYSE: ACB) sizzling momentum appears to have fizzled. Shares of the Canadian cannabis producer were tanking 12.9% as of 2:44 p.m. EDT on Tuesday. Aurora posted surprisingly strong fiscal 2021 Q3 results last week, but today's decline came after MKM Partners analyst Bill Kirk wrote to cli... | What happened Aurora Cannabis' (NYSE: ACB) sizzling momentum appears to have fizzled. Aurora posted surprisingly strong fiscal 2021 Q3 results last week, but today's decline came after MKM Partners analyst Bill Kirk wrote to clients that the company isn't "out of the woods yet." Aurora's goal to generate positive adjus... | What happened Aurora Cannabis' (NYSE: ACB) sizzling momentum appears to have fizzled. Shares of the Canadian cannabis producer were tanking 12.9% as of 2:44 p.m. EDT on Tuesday. So what No psychic skills were needed to predict that Aurora's stock couldn't continue to soar as it has over the last couple of trading days. | What happened Aurora Cannabis' (NYSE: ACB) sizzling momentum appears to have fizzled. Aurora posted surprisingly strong fiscal 2021 Q3 results last week, but today's decline came after MKM Partners analyst Bill Kirk wrote to clients that the company isn't "out of the woods yet." Here's The Marijuana Stock You've Been W... | What happened Aurora Cannabis' (NYSE: ACB) sizzling momentum appears to have fizzled. Shares of the Canadian cannabis producer were tanking 12.9% as of 2:44 p.m. EDT on Tuesday. Now what What's next for Aurora? |
37494.0 | 2020-05-19 00:00:00 UTC | Aurora Cannabis (ACB) Has a Positive Outlook, But the Stock Needs to Settle Down | ACB | https://www.nasdaq.com/articles/aurora-cannabis-acb-has-a-positive-outlook-but-the-stock-needs-to-settle-down-2020-05-19 | nan | nan | The share price of Aurora Cannabis (ACB) has been exploding since the company released its surprisingly positive earnings. The report showed the company generating much more revenue than expected, while revealing the numbers associated with cutting costs and expenditures.
Investors need to be very cautious now that it ... | The share price of Aurora Cannabis (ACB) has been exploding since the company released its surprisingly positive earnings. Indeed, most of Wall Street is surveying the cannabis producer from the sidelines, with TipRanks analytics demonstrating ACB as a Hold. The most important takeaway for me in the quarter was how Aur... | The share price of Aurora Cannabis (ACB) has been exploding since the company released its surprisingly positive earnings. Indeed, most of Wall Street is surveying the cannabis producer from the sidelines, with TipRanks analytics demonstrating ACB as a Hold. Surprising results The market was surprised by the revenue ge... | The share price of Aurora Cannabis (ACB) has been exploding since the company released its surprisingly positive earnings. Indeed, most of Wall Street is surveying the cannabis producer from the sidelines, with TipRanks analytics demonstrating ACB as a Hold. That and the company continuing to be a market leader in cost... | The share price of Aurora Cannabis (ACB) has been exploding since the company released its surprisingly positive earnings. Indeed, most of Wall Street is surveying the cannabis producer from the sidelines, with TipRanks analytics demonstrating ACB as a Hold. (See Aurora stock analysis on TipRanks) In this article, howe... |
37495.0 | 2020-05-18 00:00:00 UTC | Aurora Cannabis' Q3 Report Is a Train Wreck | ACB | https://www.nasdaq.com/articles/aurora-cannabis-q3-report-is-a-train-wreck-2020-05-18 | nan | nan | After much anticipation, the most popular cannabis stock on the planet, Aurora Cannabis (NYSE: ACB), lifted the hood on its fiscal third-quarter operating results this past Thursday, May 14.
For the quarter, Aurora managed to report $75.5 million Canadian in net sales, representing a 35% increase from the charge-laden ... | After much anticipation, the most popular cannabis stock on the planet, Aurora Cannabis (NYSE: ACB), lifted the hood on its fiscal third-quarter operating results this past Thursday, May 14. A deeper dive into Aurora's regulatory filing with SEDAR in Canada, and a thorough read of its operating results press release, s... | After much anticipation, the most popular cannabis stock on the planet, Aurora Cannabis (NYSE: ACB), lifted the hood on its fiscal third-quarter operating results this past Thursday, May 14. Having previously forecast only modest sales growth in the sequential quarter, the 35% net sales increase (and 32% net cannabis r... | After much anticipation, the most popular cannabis stock on the planet, Aurora Cannabis (NYSE: ACB), lifted the hood on its fiscal third-quarter operating results this past Thursday, May 14. For the quarter, Aurora managed to report $75.5 million Canadian in net sales, representing a 35% increase from the charge-laden ... | After much anticipation, the most popular cannabis stock on the planet, Aurora Cannabis (NYSE: ACB), lifted the hood on its fiscal third-quarter operating results this past Thursday, May 14. For the quarter, Aurora managed to report $75.5 million Canadian in net sales, representing a 35% increase from the charge-laden ... |
37496.0 | 2020-05-18 00:00:00 UTC | Aurora Cannabis Moving in the Right Direction, But Still Has a Way to Go, Says Analyst | ACB | https://www.nasdaq.com/articles/aurora-cannabis-moving-in-the-right-direction-but-still-has-a-way-to-go-says-analyst-2020 | nan | nan | Following a woeful year, the end of last week provided a sense of turnaround for investors of Aurora Cannabis (ACB). The stock shot up over 90% after the release of a better-than-expected earnings report.
The company delivered on several key issues weighing on investors’ minds ahead of the results. First of all, Aurora... | Following a woeful year, the end of last week provided a sense of turnaround for investors of Aurora Cannabis (ACB). Recreational cannabis sales jumped 24% to CA$41.5 million, boosted by the success of value brand Daily Special’s February launch. Even though CIBC analyst John Zamparo believes Aurora is “making progress... | Following a woeful year, the end of last week provided a sense of turnaround for investors of Aurora Cannabis (ACB). Although still a way off from being positive, Aurora reported an adjusted EBITDA loss of CA$45.9 million, (excluding one-time staff reduction termination costs), a vast improvement on the previous quarte... | Following a woeful year, the end of last week provided a sense of turnaround for investors of Aurora Cannabis (ACB). Although still a way off from being positive, Aurora reported an adjusted EBITDA loss of CA$45.9 million, (excluding one-time staff reduction termination costs), a vast improvement on the previous quarte... | Following a woeful year, the end of last week provided a sense of turnaround for investors of Aurora Cannabis (ACB). First of all, Aurora delivered much better sales than anticipated. Although still a way off from being positive, Aurora reported an adjusted EBITDA loss of CA$45.9 million, (excluding one-time staff redu... |
37497.0 | 2020-05-18 00:00:00 UTC | Stock Market Wrap-Up: The Real Reason Aurora Cannabis Stock Lit Up on Monday | ACB | https://www.nasdaq.com/articles/stock-market-wrap-up%3A-the-real-reason-aurora-cannabis-stock-lit-up-on-monday-2020-05-18 | nan | nan | The stock market soared on Monday, lifted by fresh enthusiasm about the possibility of the U.S. economy getting back to normal. Despite concerns from health officials, many states are moving forward with plans to reopen at least partially, and the resulting boost in economic activity has investors hoping for the best. ... | Yet gains of 2% to 4% for the major benchmarks were nothing compared to the big pop that pot stock Aurora Cannabis (NYSE: ACB) enjoyed. Those cost-control measures helped slow the rate at which Aurora is burning through its cash reserves, and the pot company hopes that it can post positive financial results after takin... | Yet gains of 2% to 4% for the major benchmarks were nothing compared to the big pop that pot stock Aurora Cannabis (NYSE: ACB) enjoyed. Selling pot stocks short worked well in 2019, earning institutional investors almost $800 million, and Aurora in particular has had a considerable number of shares sold short for a lon... | Yet gains of 2% to 4% for the major benchmarks were nothing compared to the big pop that pot stock Aurora Cannabis (NYSE: ACB) enjoyed. Selling pot stocks short worked well in 2019, earning institutional investors almost $800 million, and Aurora in particular has had a considerable number of shares sold short for a lon... | Yet gains of 2% to 4% for the major benchmarks were nothing compared to the big pop that pot stock Aurora Cannabis (NYSE: ACB) enjoyed. Selling pot stocks short worked well in 2019, earning institutional investors almost $800 million, and Aurora in particular has had a considerable number of shares sold short for a lon... |
37498.0 | 2020-05-18 00:00:00 UTC | Why Aurora Cannabis Stock Is Soaring Today | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-stock-is-soaring-today-2020-05-18 | nan | nan | What happened
Aurora Cannabis (NYSE: ACB), a small-cap Canadian pot company, is starting the week off on the right foot. The company's shares are up 72% on sky-high volume as of 10:43 a.m. EDT Monday morning.
The spark? Last Friday, Aurora's stock lit up after the company released a better-than-expected third-quarter 2... | What happened Aurora Cannabis (NYSE: ACB), a small-cap Canadian pot company, is starting the week off on the right foot. Investors, for their part, seem to be taking this quarterly revenue beat as a sign that Aurora's business may finally be nearing an inflection point. The core issues that weighed on Aurora over the p... | What happened Aurora Cannabis (NYSE: ACB), a small-cap Canadian pot company, is starting the week off on the right foot. Investors, for their part, seem to be taking this quarterly revenue beat as a sign that Aurora's business may finally be nearing an inflection point. After all, the newsletter they have run for over ... | What happened Aurora Cannabis (NYSE: ACB), a small-cap Canadian pot company, is starting the week off on the right foot. Last Friday, Aurora's stock lit up after the company released a better-than-expected third-quarter 2020 earnings report. * David and Tom just revealed what they believe are the ten best stocks for in... | What happened Aurora Cannabis (NYSE: ACB), a small-cap Canadian pot company, is starting the week off on the right foot. Investors appear to be bidding up this popular pot stock for the same reason today. So what Aurora's Q3 report has been a big hit with investors for two fundamental reasons. |
37499.0 | 2020-05-18 00:00:00 UTC | Weekly Cannabis Stock News: Aurora Cannabis Posts a Q3 Surprise | ACB | https://www.nasdaq.com/articles/weekly-cannabis-stock-news%3A-aurora-cannabis-posts-a-q3-surprise-2020-05-18 | nan | nan | The standout star of the marijuana industry last week was unquestionably Aurora Cannabis (NYSE: ACB). In a sector that is starved for good news, Aurora delivered with its Q3 results, showing improvement in several areas that badly needed some.
There was also cause for cautious optimism on the legal front, with Democra... | The standout star of the marijuana industry last week was unquestionably Aurora Cannabis (NYSE: ACB). There was also cause for cautious optimism on the legal front, with Democrats stuffing cannabis banking reform into the HEROES Act, the latest stimulus bill to be passed by the House of Representatives. More encouragin... | The standout star of the marijuana industry last week was unquestionably Aurora Cannabis (NYSE: ACB). There was also cause for cautious optimism on the legal front, with Democrats stuffing cannabis banking reform into the HEROES Act, the latest stimulus bill to be passed by the House of Representatives. The HEROES Act ... | The standout star of the marijuana industry last week was unquestionably Aurora Cannabis (NYSE: ACB). Aurora rocks revenue in Q3 Aurora is one of the largest cannabis stocks by market capitalization, but frequently it's been the largest disappointment of all. The HEROES Act banks on cannabis Could marijuana companies g... | The standout star of the marijuana industry last week was unquestionably Aurora Cannabis (NYSE: ACB). There was also cause for cautious optimism on the legal front, with Democrats stuffing cannabis banking reform into the HEROES Act, the latest stimulus bill to be passed by the House of Representatives. For the quarter... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.